{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:16:44Z","timestamp":1788304604864,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":319,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_1","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:49:45Z","timestamp":1788302985000},"page":"1-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Immunology of Transfusion Medicine: Past, Present, and Future"],"prefix":"10.1007","author":[{"given":"Connie M.","family":"Arthur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21307\/immunohematology-2019-231","volume":"25","author":"JR Storry","year":"2009","unstructured":"Storry JR, Olsson ML (2009) The ABO blood group system revisited: a review and update. Immunohematology 25:48\u201359","journal-title":"Immunohematology"},{"key":"1_CR2","first-page":"357","volume":"27","author":"K Landsteiner","year":"1900","unstructured":"Landsteiner K (1900) Zentbl Bakt Parasitkde (Abt) 27:357\u2013363","journal-title":"Zentbl Bakt Parasitkde (Abt)"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1365-3148.2001.00321.x","volume":"11","author":"WM Watkins","year":"2001","unstructured":"Watkins WM (2001) The ABO blood group system: historical background. Transfus Med 11:243\u2013265","journal-title":"Transfus Med"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/vox.12786","volume":"114","author":"SR Stowell","year":"2019","unstructured":"Stowell SR, Stowell CP (2019) Biologic roles of the ABH and Lewis histo-blood group antigens part II: thrombosis, cardiovascular disease and metabolism. Vox Sang 114:535","journal-title":"Vox Sang"},{"key":"1_CR5","doi-asserted-by":"crossref","unstructured":"W. S. Jajosky RP, Zheng L, Jajosky AN, Jajoksy PG, Josephson CD, Hollenhorst MA, Sackstein R, Cummings RD, Arthur CM, Stowell SR (2023) ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies. iScience. in press","DOI":"10.1016\/j.isci.2022.105798"},{"key":"1_CR6","doi-asserted-by":"crossref","unstructured":"McRae HL, Millar MW, Slavin SA, Blumberg N, Rahman A, Refaai MA (2021) Essential role of rho-associated kinase in ABO immune complex-mediated endothelial barrier disruption. Biomedicine 9","DOI":"10.3390\/biomedicines9121851"},{"key":"1_CR7","unstructured":"O. M. Arthur CM, Stowell SR, ABO and other carbohydrate blood group systems. C. Cohn, Ed., AABB technical manual (AABB, 21, 2023)"},{"key":"1_CR8","doi-asserted-by":"crossref","unstructured":"Arthur CM SS (2023) The development and consequences of RBC alloimmunization. Ann Rev Pathol. in press","DOI":"10.1146\/annurev-pathol-042320-110411"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/vox.12787","volume":"114","author":"CP Stowell","year":"2019","unstructured":"Stowell CP, Stowell SR (2019) Biologic roles of the ABH and Lewis histo-blood group antigens part I: infection and immunity. Vox Sang 114:426\u2013442","journal-title":"Vox Sang"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.healun.2024.03.019","volume":"43","author":"N Bansal","year":"2024","unstructured":"Bansal N, West LJ, Simmonds J, Urschel S (2024) ABO-incompatible heart transplantation-evolution of a revolution. J Heart Lung Transplant 43:1514\u20131520","journal-title":"J Heart Lung Transplant"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MOP.0000000000000398","volume":"28","author":"S Urschel","year":"2016","unstructured":"Urschel S, West LJ (2016) ABO-incompatible heart transplantation. Curr Opin Pediatr 28:613\u2013619","journal-title":"Curr Opin Pediatr"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1111\/trf.14775","volume":"58","author":"CL Dean","year":"2018","unstructured":"Dean CL, Sullivan HC, Stowell SR, Fasano RM, West LJ, Robitaille N, Josephson CD (2018) Current state of transfusion practices for ABO-incompatible pediatric heart transplant patients in the United States and Canada. Transfusion 58:2243\u20132249","journal-title":"Transfusion"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1016\/S2352-3026(23)00066-2","volume":"10","author":"F Pirenne","year":"2023","unstructured":"Pirenne F, Floch A, Diop S (2023) Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries. Lancet Haematol 10:e468\u2013e476","journal-title":"Lancet Haematol"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1182\/asheducation-2016.1.452","volume":"2016","author":"JC Zimring","year":"2016","unstructured":"Zimring JC, Hudson KE (2016) Cellular immune responses in red blood cell alloimmunization. Hematology Am Soc Hematol Educ Program 2016:452\u2013456","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/voxs.12296","volume":"12","author":"K Yazdanbakhsh","year":"2017","unstructured":"Yazdanbakhsh K, Shaz BH, Hillyer CD (2017) Immune regulation of sickle cell Alloimmunization. ISBT Sci Ser 12:248\u2013253","journal-title":"ISBT Sci Ser"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","volume":"131","author":"F Pirenne","year":"2018","unstructured":"Pirenne F, Yazdanbakhsh K (2018) How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood 131:2773\u20132781","journal-title":"Blood"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1182\/blood-2018-08-833962","volume":"133","author":"CA Tormey","year":"2019","unstructured":"Tormey CA, Hendrickson JE (2019) Transfusion-related red blood cell alloantibodies: induction and consequences. Blood 133:1821\u20131830","journal-title":"Blood"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-pathol-012414-040318","volume":"10","author":"JC Zimring","year":"2015","unstructured":"Zimring JC, Spitalnik SL (2015) Pathobiology of transfusion reactions. Annu Rev Pathol 10:83\u2013110","journal-title":"Annu Rev Pathol"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MOH.0000000000000540","volume":"26","author":"KE Hudson","year":"2019","unstructured":"Hudson KE, Fasano RM, Karafin MS, Hendrickson JE, Francis RO (2019) Mechanisms of alloimmunization in sickle cell disease. Curr Opin Hematol 26:434\u2013441","journal-title":"Curr Opin Hematol"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/vox.12265","volume":"109","author":"M de Haas","year":"2015","unstructured":"de Haas M, Thurik FF, Koelewijn JM, van der Schoot CE (2015) Haemolytic disease of the fetus and newborn. Vox Sang 109:99\u2013113","journal-title":"Vox Sang"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/vox.13651","volume":"119","author":"C Zwiers","year":"2024","unstructured":"Zwiers C, Slootweg YM, Koelewijn JM, Ligthart PC, van der Bom JG, van Kamp IL, Lopriore E, van der Schoot CE, Oepkes D, de Haas M (2024) Disease severity in subsequent pregnancies with RhD immunization: a nationwide cohort. Vox Sang 119:859\u2013866","journal-title":"Vox Sang"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1182\/blood-2016-07-724989","volume":"128","author":"SR Stowell","year":"2016","unstructured":"Stowell SR (2016) Working together to block alloimmunization. Blood 128:1029\u20131030","journal-title":"Blood"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-pathol-042320-110411","volume":"18","author":"CM Arthur","year":"2023","unstructured":"Arthur CM, Stowell SR (2023) The development and consequences of red blood cell Alloimmunization. Annu Rev Pathol 18:537\u2013564","journal-title":"Annu Rev Pathol"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/asheducation-2009.1.185","volume":"2009","author":"D Brinc","year":"2009","unstructured":"Brinc D, Lazarus AH (2009) Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn. Hematology Am Soc Hematol Educ Program 2009:185\u2013191","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1111\/trf.15307","volume":"59","author":"S Vossoughi","year":"2019","unstructured":"Vossoughi S, Spitalnik SL (2019) Conquering erythroblastosis fetalis: 50 years of RhIG. Transfusion 59:2195\u20132196","journal-title":"Transfusion"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"227 e221","DOI":"10.1016\/j.ajog.2019.05.019","volume":"221","author":"GHA Visser","year":"2019","unstructured":"Visser GHA, Di Renzo GC, Spitalnik SL, Motherhood FCS, Newborn H (2019) The continuing burden of Rh disease 50 years after the introduction of anti-Rh (D) immunoglobin prophylaxis: call to action. Am J Obstet Gynecol 221:227 e221\u2013227 e224","journal-title":"Am J Obstet Gynecol"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bjh.12372","volume":"162","author":"O Salomon","year":"2013","unstructured":"Salomon O, Rosenberg N (2013) Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia. Br J Haematol 162:304\u2013312","journal-title":"Br J Haematol"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/vox.13777","volume":"120","author":"C Calandrini","year":"2025","unstructured":"Calandrini C, Verhagen O, Tissoudali A, Homburg CHE, Vessies J, Brussee M, van Beers EH, van der Schoot CE, de Haas M (2025) Real-world performance of a clinical droplet digital polymerase chain reaction assay for non-invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies directed against RhD, RhE, Rhc, RhC, K1, HPA-1a or HPA-5b: a 1-year experience. Vox Sang 120:170\u2013177","journal-title":"Vox Sang"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/vox.13779","volume":"120","author":"TW de Vos","year":"2025","unstructured":"de Vos TW, Tersteeg I, Lopriore E, Oepkes D, Porcelijn L, van der Schoot CE, Verweij EJT, Winkelhorst D, de Haas M, van den Akker-van Marle ME (2025) Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: a cost-utility analysis. Vox Sang 120:178\u2013187","journal-title":"Vox Sang"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/j.1537-2995.2011.03480.x","volume":"52","author":"H Tiller","year":"2012","unstructured":"Tiller H, Killie MK, Chen P, Eksteen M, Husebekk A, Skogen B, Kjeldsen-Kragh J, Ni H (2012) Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. Transfusion 52:1446\u20131457","journal-title":"Transfusion"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1182\/blood.2021011131","volume":"138","author":"X Xu","year":"2021","unstructured":"Xu X, Chen D, Ye X, Xia W, Xu Y, Chen Y, Shao Y, Deng J, Ding H, Liu J, Wang J, Ni H, Fu Y, Santoso S (2021) Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model. Blood 138:1757\u20131767","journal-title":"Blood"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1537-2995.2012.03700.x","volume":"52","author":"BM Kumpel","year":"2012","unstructured":"Kumpel BM (2012) Would it be possible to prevent HPA-1a alloimmunization to reduce the incidence of fetal and neonatal alloimmune thrombocytopenia? Transfusion 52:1393\u20131397","journal-title":"Transfusion"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","volume":"337","author":"G. Trial to reduce Alloimmunization to platelets study","year":"1997","unstructured":"G. Trial to reduce Alloimmunization to platelets study (1997) leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 337:1861\u20131869","journal-title":"N Engl J Med"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"e985","DOI":"10.1016\/S2352-3026(23)00271-5","volume":"10","author":"TW de Vos","year":"2023","unstructured":"de Vos TW, Winkelhorst D, Porcelijn L, Beaufort M, Oldert G, van der Bom JG, Lopriore E, Oepkes D, de Haas M, van der Schoot E (2023) Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study. Lancet Haematol 10:e985\u2013e993","journal-title":"Lancet Haematol"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/trf.17758","volume":"64","author":"JJ Oosterhoff","year":"2024","unstructured":"Oosterhoff JJ, Linty F, Visser R, de Vos T, Hofstede-van Egmond S, van de Weerd M, Porcelijn L, de Haas M, van der Schoot E, Vidarsson G (2024) Generation of human antibodies targeting human platelet antigen (HPA)-1a. Transfusion 64:893\u2013905","journal-title":"Transfusion"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1182\/bloodadvances.2021004371","volume":"5","author":"H Zhi","year":"2021","unstructured":"Zhi H, Ahlen MT, Skogen B, Newman DK, Newman PJ (2021) Preclinical evaluation of immunotherapeutic regimens for fetal\/neonatal alloimmune thrombocytopenia. Blood Adv 5:3552\u20133562","journal-title":"Blood Adv"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1182\/blood.2022015666","volume":"140","author":"H Zhi","year":"2022","unstructured":"Zhi H, Sheridan D, Newman DK, Newman PJ (2022) Prophylactic administration of HPA-1a-specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice. Blood 140:2146\u20132153","journal-title":"Blood"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1172\/JCI57850","volume":"121","author":"C Li","year":"2011","unstructured":"Li C, Piran S, Chen P, Lang S, Zarpellon A, Jin JW, Zhu G, Reheman A, van der Wal DE, Simpson EK, Ni R, Gross PL, Ware J, Ruggeri ZM, Freedman J, Ni H (2011) The maternal immune response to fetal platelet GPIbalpha causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. J Clin Invest 121:4537\u20134547","journal-title":"J Clin Invest"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMoa2314466","volume":"391","author":"KJ Moise Jr","year":"2024","unstructured":"Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij E, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocon-Hernandez O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB, U. S. Group (2024) Nipocalimab in early-onset severe hemolytic disease of the fetus and Newborn. N Engl J Med 391:526\u2013537","journal-title":"N Engl J Med"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","volume":"116","author":"P Chen","year":"2010","unstructured":"Chen P, Li C, Lang S, Zhu G, Reheman A, Spring CM, Freedman J, Ni H (2010) Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal fc receptor in the pathogenesis and therapy. Blood 116:3660\u20133668","journal-title":"Blood"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","volume":"225","author":"JB Bussel","year":"2021","unstructured":"Bussel JB, Vander Haar EL, Berkowitz RL (2021) New developments in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 225:120\u2013127","journal-title":"Am J Obstet Gynecol"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1016\/S2352-3026(16)30043-6","volume":"3","author":"WA Flegel","year":"2016","unstructured":"Flegel WA (2016) Red cell alloimmunisation: incidence and prevention. Lancet Haematol 3:e260\u2013e261","journal-title":"Lancet Haematol"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/trf.18135","volume":"65","author":"H Yu","year":"2025","unstructured":"Yu H, Karafin MS, Tormey CA, Goel R, Spencer BR, Hendrickson JE, Hauser RG (2025) Associations between blood donors, component modifications, and the alloimmunization of transfusion recipients. Transfusion 65:588\u2013603","journal-title":"Transfusion"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/trf.13379","volume":"56","author":"RS Nickel","year":"2016","unstructured":"Nickel RS, Hendrickson JE, Fasano RM, Meyer EK, Winkler AM, Yee MM, Lane PA, Jones YA, Pashankar FD, New T, Josephson CD, Stowell SR (2016) Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series. Transfusion 56:107\u2013114","journal-title":"Transfusion"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/trf.15010","volume":"59","author":"CL Dean","year":"2019","unstructured":"Dean CL, Maier CL, Roback JD, Stowell SR (2019) Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease. Transfusion 59:448\u2013453","journal-title":"Transfusion"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1182\/bloodadvances.2022006982","volume":"6","author":"E Viayna","year":"2022","unstructured":"Viayna E, Gehrie EA, Blanchette C, Meny GM, Noumsi G, Huber M, Runken MC (2022) Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality. Blood Adv 6:5655\u20135658","journal-title":"Blood Adv"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/trf.12940","volume":"55","author":"MJ Telen","year":"2015","unstructured":"Telen MJ, Afenyi-Annan A, Garrett ME, Combs MR, Orringer EP, Ashley-Koch AE (2015) Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion 55:1378\u20131387","journal-title":"Transfusion"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1111\/trf.13704","volume":"56","author":"G Stack","year":"2016","unstructured":"Stack G, Tormey CA (2016) Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence. Transfusion 56:2662\u20132667","journal-title":"Transfusion"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/trf.15718","volume":"60","author":"RG Hauser","year":"2020","unstructured":"Hauser RG, Esserman D, Karafin MS, Tan S, Balbuena-Merle R, Spencer BR, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Gottschall JL, Hendrickson JE, Tormey CA (2020) The evanescence and persistence of RBC alloantibodies in blood donors. Transfusion 60:831\u2013839","journal-title":"Transfusion"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.tracli.2019.02.002","volume":"26","author":"RM Fasano","year":"2019","unstructured":"Fasano RM, Miller MJ, Chonat S, Stowell SR (2019) Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease. Transfus Clin Biol 26:94\u201398","journal-title":"Transfus Clin Biol"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.14423\/SMJ.0000000000000528","volume":"109","author":"LA Williams 3rd","year":"2016","unstructured":"Williams LA 3rd, Lorenz RG, Tahir A, Pham HP, Marques MB (2016) High percentage of evanescent red cell antibodies in patients with sickle cell disease highlights need for a National Antibody Database. South Med J 109:588\u2013591","journal-title":"South Med J"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bjh.13339","volume":"169","author":"JB Vidler","year":"2015","unstructured":"Vidler JB, Gardner K, Amenyah K, Mijovic A, Thein SL (2015) Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience. Br J Haematol 169:746\u2013753","journal-title":"Br J Haematol"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/ajh.24908","volume":"92","author":"D Narbey","year":"2017","unstructured":"Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelievre JD, Godeau B, Michel M, Galacteros F, Djoudi R, Bartolucci P, Pirenne F (2017) Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease. Am J Hematol 92:1340\u20131348","journal-title":"Am J Hematol"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3324\/haematol.2022.281050","volume":"108","author":"C Falguiere","year":"2023","unstructured":"Falguiere C, Allali S, Khazem B, Kamdem A, Arnaud C, Belloy M, Guitton C, Odievre MH, Pertuisel S, Dumesnil C, Guillaumat C, Garrec N, Gauthier A, Mahe P, Soussan-Banini V, Le-Carrer L, Merlin E, David A, Pellegrino B, Paillard C, Brasme JF, Lagarde M, Pirenne F, Pondarre C (2023) Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France. Haematologica 108:889\u2013894","journal-title":"Haematologica"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3324\/haematol.2019.224709","volume":"105","author":"SL Thein","year":"2020","unstructured":"Thein SL, Pirenne F, Fasano RM, Habibi A, Bartolucci P, Chonat S, Hendrickson JE, Stowell SR (2020) Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal. Haematologica 105:539\u2013544","journal-title":"Haematologica"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ajh.27211","volume":"99","author":"S Ito","year":"2024","unstructured":"Ito S, Pandya A, Hauser RG, Krishnamurti L, Stites E, Tormey C, Krumholz HM, Hendrickson JE, Goshua G (2024) Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: cost-effectiveness of a shared transfusion resource. Am J Hematol 99:570\u2013576","journal-title":"Am J Hematol"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/trf.16967","volume":"62","author":"ML Covington","year":"2022","unstructured":"Covington ML, Cone-Sullivan JK, Andrzejewski C, Lu W, Thomasson RR, O'Brien K, Brunker PAR, Stowell SR (2022) Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: challenges and opportunities for improvement. Transfusion 62:1662\u20131670","journal-title":"Transfusion"},{"key":"1_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104211","volume":"52","author":"DY Chang","year":"2023","unstructured":"Chang DY, Wankier Z, Arthur CM, Stowell SR (2023) The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease. Presse Med 52:104211","journal-title":"Presse Med"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/trf.15004","volume":"59","author":"MS Karafin","year":"2019","unstructured":"Karafin MS, Tan S, Tormey CA, Spencer BR, Hauser RG, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Gottschall JL, Hendrickson JE (2019) Prevalence and risk factors for RBC alloantibodies in blood donors in the recipient Epidemiology and Donor Evaluation study-III (REDS-III). Transfusion 59:217\u2013225","journal-title":"Transfusion"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1537-2995.1962.tb00260.x","volume":"2","author":"H Chaplin Jr","year":"1962","unstructured":"Chaplin H Jr, Cassell M (1962) The occasional fallibility of in vitro compatibility tests. Transfusion 2:375\u2013384","journal-title":"Transfusion"},{"key":"1_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2020.102946","volume":"59","author":"GK Gupta","year":"2020","unstructured":"Gupta GK, Balbuena-Merle R, Hendrickson JE, Tormey CA (2020) Immunohematologic aspects of alloimmunization and alloantibody detection: a focus on pregnancy and hemolytic disease of the fetus and newborn. Transfus Apher Sci 59:102946","journal-title":"Transfus Apher Sci"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5858\/arpa.2015-0444-RS","volume":"141","author":"V Parker","year":"2017","unstructured":"Parker V, Tormey CA (2017) The direct Antiglobulin test: indications, interpretation, and pitfalls. Arch Pathol Lab Med 141:305\u2013310","journal-title":"Arch Pathol Lab Med"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1182\/hematology.2023000499","volume":"2023","author":"F Pirenne","year":"2023","unstructured":"Pirenne F, Pondarre C (2023) Alloimmunization and hyperhemolysis in sickle cell disease. Hematology Am Soc Hematol Educ Program 2023:653\u2013659","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1111\/trf.15463","volume":"59","author":"R Balbuena-Merle","year":"2019","unstructured":"Balbuena-Merle R, Curtis SA, Devine L, Gibb DR, Karafin MS, Luckey CJ, Tormey CA, Siddon AJ, Roberts JD, Hendrickson JE (2019) Red blood cell alloimmunization is associated with lower expression of FcgammaR1 on monocyte subsets in patients with sickle cell disease. Transfusion 59:3219\u20133227","journal-title":"Transfusion"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/trf.15562","volume":"60","author":"LE Lee","year":"2020","unstructured":"Lee LE, Beeler BW, Graham BC, Cap AP, Win N, Chen F (2020) Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab. Transfusion 60:30\u201335","journal-title":"Transfusion"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/trf.16805","volume":"62","author":"J Meenan","year":"2022","unstructured":"Meenan J, Hall R, Badle S, Chatterjee B, Win N, Tsitsikas DA (2022) Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: the experience so far. Transfusion 62:546\u2013550","journal-title":"Transfusion"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/hematolrep14030032","volume":"14","author":"SR Menakuru","year":"2022","unstructured":"Menakuru SR, Priscu A, Dhillon V, Salih A (2022) Acute Hyperhemolysis syndrome in a patient with known sickle cell anemia refractory to steroids and IVIG treated with Tocilizumab and erythropoietin: a case report and review of literature. Hematol Rep 14:235\u2013239","journal-title":"Hematol Rep"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1182\/bloodadvances.2022009283","volume":"7","author":"ST Chou","year":"2023","unstructured":"Chou ST, Hendrickson JE, Fasano RM (2023) Transfusion therapy for sickle cell disease: what's new? Blood Adv 7:2551\u20132553","journal-title":"Blood Adv"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part I - molecular mechanisms of activation and regulation. Front Immunol 6:262","journal-title":"Front Immunol"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.tracli.2019.02.008","volume":"26","author":"NS Merle","year":"2019","unstructured":"Merle NS, Boudhabhay I, Leon J, Fremeaux-Bacchi V, Roumenina LT (2019) Complement activation during intravascular hemolysis: implication for sickle cell disease and hemolytic transfusion reactions. Transfus Clin Biol 26:116\u2013124","journal-title":"Transfus Clin Biol"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1073\/pnas.1814797116","volume":"116","author":"NS Merle","year":"2019","unstructured":"Merle NS, Paule R, Leon J, Daugan M, Robe-Rybkine T, Poillerat V, Torset C, Fremeaux-Bacchi V, Dimitrov JD, Roumenina LT (2019) P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4\/heme-dependent manner. Proc Natl Acad Sci USA 116:6280\u20136285","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tmrv.2019.09.007","volume":"33","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Bartolucci P, Pirenne F (2019) The role of complement in post-transfusion hemolysis and Hyperhemolysis reaction. Transfus Med Rev 33:225\u2013230","journal-title":"Transfus Med Rev"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","volume":"127","author":"G Dumas","year":"2016","unstructured":"Dumas G, Habibi A, Onimus T, Merle JC, Razazi K, Mekontso Dessap A, Galacteros F, Michel M, Fremeaux Bacchi V, Noizat Pirenne F, Bartolucci P (2016) Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients. Blood 127:1062\u20131064","journal-title":"Blood"},{"key":"1_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104205","volume":"52","author":"MS Meuleman","year":"2023","unstructured":"Meuleman MS, Roumenina LT, Grunenwald A (2023) Complement involvement in sickle cell disease. Presse Med 52:104205","journal-title":"Presse Med"},{"key":"1_CR75","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ajh.25742","volume":"95","author":"LT Roumenina","year":"2020","unstructured":"Roumenina LT, Chadebech P, Bodivit G, Vieira-Martins P, Grunenwald A, Boudhabhay I, Poillerat V, Pakdaman S, Kiger L, Jouard A, Audureau E, Pirenne F, Galacteros F, Fremeaux-Bacchi V, Bartolucci P (2020) Complement activation in sickle cell disease: dependence on cell density, hemolysis and modulation by hydroxyurea therapy. Am J Hematol 95:456\u2013464","journal-title":"Am J Hematol"},{"key":"1_CR76","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1172\/JCI116706","volume":"92","author":"RH Wang","year":"1993","unstructured":"Wang RH, Phillips G, Medof ME, Mold C (1993) Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest 92:1326\u20131335","journal-title":"J Clin Invest"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1182\/blood.2022019282","volume":"142","author":"ZK Ivy","year":"2023","unstructured":"Ivy ZK, Belcher JD, Khasabova IA, Chen C, Juliette JP, Abdulla F, Ruan C, Allen K, Nguyen J, Rogness VM, Beckman JD, Khasabov SG, Gupta K, Taylor RP, Simone DA, Vercellotti GM (2023) Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation. Blood 142:1918\u20131927","journal-title":"Blood"},{"key":"1_CR78","first-page":"130","volume":"36","author":"WA Wilson","year":"1979","unstructured":"Wilson WA, Thomas EJ, Sissons JG (1979) Complement activation in asymptomatic patients with sickle cell anaemia. Clin Exp Immunol 36:130\u2013139","journal-title":"Clin Exp Immunol"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/clin.1994.1072","volume":"71","author":"DS Chudwin","year":"1994","unstructured":"Chudwin DS, Papierniak C, Lint TF, Korenblit AD (1994) Activation of the alternative complement pathway by red blood cells from patients with sickle cell disease. Clin Immunol Immunopathol 71:199\u2013202","journal-title":"Clin Immunol Immunopathol"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1055\/s-0038-1672189","volume":"2","author":"JG Nolasco","year":"2018","unstructured":"Nolasco JG, Nolasco LH, Da Q, Cirlos S, Ruggeri ZM, Moake JL, Cruz MA (2018) Complement component C3 binds to the A3 domain of von Willebrand factor. TH Open 2:e338\u2013e345","journal-title":"TH Open"},{"key":"1_CR81","doi-asserted-by":"crossref","unstructured":"Vercellotti GM, Dalmasso AP, Schaid TR Jr, Nguyen J, Chen C, Ericson ME, Abdulla F, Killeen T, Lindorfer MA, Taylor RP, Belcher JD (2018) Critical role of C5a in sickle cell disease. Am J Hematol:1\u201341","DOI":"10.1002\/ajh.25384"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1182\/blood-2022-170830","volume":"140","author":"S Chonat","year":"2022","unstructured":"Chonat S, Jones JA, Patel SR, Zerra PE, Jeffers LA, Jajosky RP, Arthur CM, Koval M, Joiner CH, Archer DR, Stowell SR (2022) Complement drives acute chest syndrome in a model of sickle cell disease. Blood 140:8221\u20138222","journal-title":"Blood"},{"key":"1_CR83","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl4922","volume":"17","author":"S Chonat","year":"2025","unstructured":"Chonat S, Jones JA, Patel SR, Briones WM, Schoettler ML, Maarouf M, Jeffers LA, Adisa O, Tan F, Fields E, Sterling MS, Jajosky RP, Verkerke H, Graciaa SH, Foppiani EM, Fasano RM, Zerra PE, Qiu Y, Arthur CM, Lam WA, Ofori-Acquah SF, Koval M, Joiner CH, Archer DR, Stowell SR (2025) Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target. Sci Transl Med 17:eadl4922","journal-title":"Sci Transl Med"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.3324\/haematol.2020.262006","volume":"105","author":"S Chonat","year":"2020","unstructured":"Chonat S, Graciaa S, Shin HS, Newton JG, Quarmyne MO, Boudreaux J, Tang A, Zerra PE, Rollins MR, Josephson CD, Brown C, Joiner CH, Fasano RM, Stowell SR (2020) Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease. Haematologica 105:2887\u20132891","journal-title":"Haematologica"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","volume":"103","author":"S Chonat","year":"2018","unstructured":"Chonat S, Quarmyne MO, Bennett CM, Dean CL, Joiner CH, Fasano RM, Stowell SR (2018) Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease. Haematologica 103:e483\u2013e485","journal-title":"Haematologica"},{"key":"1_CR86","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1182\/blood.2023021658","volume":"143","author":"Y Han","year":"2024","unstructured":"Han Y, Gao C, Liu Y, Zhang H, Wang S, Zhao H, Bao W, Guo X, Vinchi F, Lobo C, Shi P, Mendelson A, Luchsinger L, Zhong H, Yazdanbakhsh K, An X (2024) Hemolysis-driven IFNalpha production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease. Blood 143:1018\u20131031","journal-title":"Blood"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000369513","volume":"41","author":"SA Campbell-Lee","year":"2014","unstructured":"Campbell-Lee SA, Kittles RA (2014) Red blood cell alloimmunization in sickle cell disease: listen to your ancestors. Transfus Med Hemother 41:431\u2013435","journal-title":"Transfus Med Hemother"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tmrv.2018.07.003","volume":"33","author":"RM Fasano","year":"2019","unstructured":"Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR (2019) Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review. Transfus Med Rev 33:12\u201323","journal-title":"Transfus Med Rev"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/bjh.13123","volume":"168","author":"RM Fasano","year":"2015","unstructured":"Fasano RM, Booth GS, Miles M, Du L, Koyama T, Meier ER, Luban NL (2015) Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease. Br J Haematol 168:291\u2013300","journal-title":"Br J Haematol"},{"key":"1_CR90","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1182\/bloodadvances.2022008647","volume":"7","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Gossett JM, Chen PL, Barton M, Ryan M, Yu J, Kang G, Hankins JS, Chou ST (2023) Proinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease. Blood Adv 7:4799\u20134808","journal-title":"Blood Adv"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/labmed\/lmae056","volume":"56","author":"L Wang","year":"2025","unstructured":"Wang L, Xu X, Wang S, Li R, Zhang P (2025) Red blood cell alloimmunization in transfused patients with myelodysplastic syndromes: a retrospective study from northern China. Lab Med 56:22\u201330","journal-title":"Lab Med"},{"key":"1_CR92","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1537-2995.2012.03819.x","volume":"53","author":"C Sanz","year":"2013","unstructured":"Sanz C, Nomdedeu M, Belkaid M, Martinez I, Nomdedeu B, Pereira A (2013) Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion 53:710\u2013715","journal-title":"Transfusion"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3324\/haematol.2017.175752","volume":"102","author":"D. Singhal","year":"2017","unstructured":"D. Singhal, Kutyna MM, Chhetri R, Wee LYA, Hague S, Nath L, Nath SV, Sinha R, Wickham N, Lewis ID, Ross DM, Bardy PG, L. B. To, Reynolds J, Wood EM, Roxby DJ, Hiwase DK (2017) Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome. Haematologica 102:2021\u20132029","journal-title":"Haematologica"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/bjh.13781","volume":"174","author":"AB Ryder","year":"2016","unstructured":"Ryder AB, Hendrickson JE, Tormey CA (2016) Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization. Br J Haematol 174:483\u2013485","journal-title":"Br J Haematol"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.15182","volume":"181","author":"MS Karafin","year":"2018","unstructured":"Karafin MS, Westlake M, Hauser RG, Tormey CA, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Hendrickson JE, Epidemiology NR, Donor Evaluation S III (2018) Risk factors for red blood cell alloimmunization in the recipient epidemiology and donor evaluation study (REDS-III) database. Br J Haematol 181:672\u2013681","journal-title":"Br J Haematol"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639\u20131644","journal-title":"N Engl J Med"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ajh.23683","volume":"89","author":"H Elmariah","year":"2014","unstructured":"Elmariah H, Garrett ME, De Castro LM, Jonassaint JC, Ataga KI, Eckman JR, Ashley-Koch AE, Telen MJ (2014) Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol 89:530\u2013535","journal-title":"Am J Hematol"},{"key":"1_CR98","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","volume":"314","author":"MH Gaston","year":"1986","unstructured":"Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS et al (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 314:1593\u20131599","journal-title":"N Engl J Med"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","volume":"2017","author":"AT Taher","year":"2017","unstructured":"Taher AT, Saliba AN (2017) Iron overload in thalassemia: different organs at different rates. Hematology Am Soc Hematol Educ Program 2017:265\u2013271","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM199807023390102","volume":"339","author":"RJ Adams","year":"1998","unstructured":"Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339:5\u201311","journal-title":"N Engl J Med"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","volume":"322","author":"EP Vichinsky","year":"1990","unstructured":"Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322:1617\u20131621","journal-title":"N Engl J Med"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","volume":"122","author":"ST Chou","year":"2013","unstructured":"Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM (2013) High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 122:1062\u20131071","journal-title":"Blood"},{"key":"1_CR103","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/bjh.17875","volume":"196","author":"J Gerritsma","year":"2022","unstructured":"Gerritsma J, Bongaerts V, Eckhardt C, Heijboer H, Nur E, Biemond B, van der Schoot E, Fijnvandraat K, Consortium S (2022) Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease. Br J Haematol 196:769\u2013776","journal-title":"Br J Haematol"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/trf.12250","volume":"54","author":"S Kacker","year":"2014","unstructured":"Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA (2014) Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients. Transfusion 54:86\u201397","journal-title":"Transfusion"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1182\/blood-2008-03-146415","volume":"112","author":"JM Higgins","year":"2008","unstructured":"Higgins JM, Sloan SR (2008) Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 112:2546\u20132553","journal-title":"Blood"},{"key":"1_CR106","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1537-2995.2010.03024.x","volume":"51","author":"JC Zimring","year":"2011","unstructured":"Zimring JC, Welniak L, Semple JW, Ness PM, Slichter SJ, Spitalnik SL, N. A. W. Group (2011) Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group. Transfusion 51:435\u2013441","journal-title":"Transfusion"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/vox.13217","volume":"117","author":"RHG van de Weem","year":"2022","unstructured":"van de Weem RHG, Wemelsfelder ML, Luken JS, de Haas M, Niessen R, van der Schoot CE, Hoogeveen H, Janssen MP (2022) Preventing alloimmunization using a new model for matching extensively typed red blood cells. Vox Sang 117:580\u2013586","journal-title":"Vox Sang"},{"key":"1_CR108","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/tme.12831","volume":"32","author":"JHJ van Sambeeck","year":"2022","unstructured":"van Sambeeck JHJ, van der Schoot CE, van Dijk NM, Schonewille H, Janssen MP (2022) Extended red blood cell matching for all transfusion recipients is feasible. Transfus Med 32:221\u2013228","journal-title":"Transfus Med"},{"key":"1_CR109","doi-asserted-by":"publisher","first-page":"129","DOI":"10.21307\/immunohematology-2020-051","volume":"36","author":"SR Joshi","year":"2020","unstructured":"Joshi SR, Senjaliya SB, Srivastava K, Flegel WA (2020) A resource-conserving serologic and highthroughput molecular approach to screen for blood donors with an IN:-5 phenotype. Immunohematology 36:129\u2013132","journal-title":"Immunohematology"},{"key":"1_CR110","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1053\/j.seminhematol.2019.11.001","volume":"56","author":"JH Carter","year":"2019","unstructured":"Carter JH, Flegel WA (2019) Red cell transfusions in the genomics era. Semin Hematol 56:236\u2013240","journal-title":"Semin Hematol"},{"key":"1_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30053-X","volume":"5","author":"WJ Lane","year":"2018","unstructured":"Lane WJ, Westhoff CM, Gleadall NS, Aguad M, Smeland-Wagman R, Vege S, Simmons DP, Mah HH, Lebo MS, Walter K, Soranzo N, Di Angelantonio E, Danesh J, Roberts DJ, Watkins NA, Ouwehand WH, Butterworth AS, Kaufman RM, Rehm HL, Silberstein LE, Green RC, P. MedSeq (2018) Automated typing of red blood cell and platelet antigens: a whole-genome sequencing study. Lancet Haematol 5:e241-e251","journal-title":"Lancet Haematol"},{"key":"1_CR112","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1111\/trf.15473","volume":"59","author":"WJ Lane","year":"2019","unstructured":"Lane WJ, Vege S, Mah HH, Lomas-Francis C, Aguad M, Smeland-Wagman R, Koch C, Killian JM, Gardner CL, De Castro M, Lebo MS, Kaufman RM, Green RC, Westhoff CM, MilSeq P (2019) Automated typing of red blood cell and platelet antigens from whole exome sequences. Transfusion 59:3253\u20133263","journal-title":"Transfusion"},{"key":"1_CR113","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1537-2995.2006.00805.x","volume":"46","author":"A Montpetit","year":"2006","unstructured":"Montpetit A, Phillips MS, Mongrain I, Lemieux R, St-Louis M (2006) High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 46:841\u2013848","journal-title":"Transfusion"},{"key":"1_CR114","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1423-0410.2009.01209.x","volume":"97","author":"B Veldhuisen","year":"2009","unstructured":"Veldhuisen B, van der Schoot CE, de Haas M (2009) Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 97:198\u2013206","journal-title":"Vox Sang"},{"key":"1_CR115","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ajt.2022.12.017","volume":"23","author":"A Joseph","year":"2023","unstructured":"Joseph A, Murray CJ, Novikov ND, Velliquette RW, Vege S, Halls JBL, Mah HH, Dellagatta JL, Comeau E, Aguad M, Kaufman RM, Olsson ML, Guleria I, Stowell SR, Milford EL, Hult AK, Yeung MY, Westhoff CM, Murphey CL, Lane WJ (2023) ABO genotyping finds more a (2) to B kidney transplant opportunities than lectin-based subtyping. Am J Transplant 23:512\u2013519","journal-title":"Am J Transplant"},{"key":"1_CR116","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/bjh.14307","volume":"175","author":"D Evers","year":"2016","unstructured":"Evers D, van der Bom JG, Tijmensen J, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Pequeriaux NC, Hudig F, Zwaginga JJ (2016) Red cell alloimmunisation in patients with different types of infections. Br J Haematol 175:956\u2013966","journal-title":"Br J Haematol"},{"key":"1_CR117","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1182\/asheducation-2016.1.446","volume":"2016","author":"JE Hendrickson","year":"2016","unstructured":"Hendrickson JE, Tormey CA (2016) Understanding red blood cell alloimmunization triggers. Hematology Am Soc Hematol Educ Program 2016:446\u2013451","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1_CR118","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1182\/asheducation-2016.1.457","volume":"2016","author":"K Yazdanbakhsh","year":"2016","unstructured":"Yazdanbakhsh K (2016) Immunoregulatory networks in sickle cell alloimmunization. Hematology Am Soc Hematol Educ Program 2016:457\u2013461","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1_CR119","doi-asserted-by":"crossref","unstructured":"Doshi BS, Rana J, Castaman G, Shaheen MA, Kaczmarek R, Butterfield JS, Meeks SL, Leissinger C, Biswas M, Arruda VR (2021) B cell-activating factor modulates the factor VIII immune response in hemophilia a. J Clin Invest 131","DOI":"10.1172\/JCI142906"},{"key":"1_CR120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood-2023-188439","volume":"142","author":"R Kaczmarek","year":"2023","unstructured":"Kaczmarek R, Pineros AR, Patterson PE, Bertolini TB, Perrin GQ, Sherman A, Born J, Arisa S, Arvin MC, Kamocka MM, Martinez MM, Dunn KW, Quinn SM, Morris JJ, Wilhelm AR, Kaisho T, Munoz-Melero M, Biswas M, Kaplan MH, Linnemann AK, George LA, Camire RM, Herzog RW (2023) Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells. Blood 142:290\u2013305","journal-title":"Blood"},{"key":"1_CR121","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3389\/fimmu.2020.00905","volume":"11","author":"PE Zerra","year":"2020","unstructured":"Zerra PE, Arthur CM, Chonat S, Maier CL, Mener A, Shin S, Allen JWL, Baldwin WH, Cox C, Verkerke H, Jajosky RP, Tormey CA, Meeks SL, Stowell SR (2020) Fc gamma receptors and complement component 3 facilitate anti-fVIII antibody formation. Front Immunol 11:905","journal-title":"Front Immunol"},{"key":"1_CR122","doi-asserted-by":"publisher","first-page":"1165973","DOI":"10.3389\/fimmu.2023.1165973","volume":"14","author":"M Khelfa","year":"2023","unstructured":"Khelfa M, Leclerc M, Kerbrat S, Boudjemai YNS, Benchouaia M, Neyrinck-Leglantier D, Cagnet L, Berradhia L, Tamagne M, Croisille L, Pirenne F, Maury S, Vingert B (2023) Divergent CD4 (+) T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients. Front Immunol 14:1165973","journal-title":"Front Immunol"},{"key":"1_CR123","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1182\/asheducation-2016.1.657","volume":"2016","author":"SL Meeks","year":"2016","unstructured":"Meeks SL, Batsuli G (2016) Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches. Hematology Am Soc Hematol Educ Program 2016:657\u2013662","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1_CR124","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1537-2995.1988.28588337338.x","volume":"28","author":"SG Brantley","year":"1988","unstructured":"Brantley SG, Ramsey G (1988) Red cell alloimmunization in multitransfused HLA-typed patients. Transfusion 28:463\u2013466","journal-title":"Transfusion"},{"key":"1_CR125","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1182\/blood-2017-05-784876","volume":"130","author":"SM Meinderts","year":"2017","unstructured":"Meinderts SM, Sins JWR, Fijnvandraat K, Nagelkerke SQ, Geissler J, Tanck MW, Bruggeman C, Biemond BJ, Rijneveld AW, Kerkhoffs JH, Pakdaman S, Habibi A, van Bruggen R, Kuijpers TW, Pirenne F, van den Berg TK (2017) Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease. Blood 130:2121\u20132130","journal-title":"Blood"},{"key":"1_CR126","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/trf.13920","volume":"57","author":"EA Sippert","year":"2017","unstructured":"Sippert EA, Visentainer JE, Alves HV, Rodrigues C, Gilli SC, Addas-Carvalho M, Saad ST, Costa FF, Castilho L (2017) Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms. Transfusion 57:379\u2013389","journal-title":"Transfusion"},{"key":"1_CR127","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/j.1537-2995.2006.00900.x","volume":"46","author":"F Noizat-Pirenne","year":"2006","unstructured":"Noizat-Pirenne F, Tournamille C, Bierling P, Roudot-Thoraval F, Le Pennec PY, Rouger P, Ansart-Pirenne H (2006) Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 46:1328\u20131333","journal-title":"Transfusion"},{"key":"1_CR128","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/bjh.15998","volume":"186","author":"SM Meinderts","year":"2019","unstructured":"Meinderts SM, Gerritsma JJ, Sins JWR, de Boer M, van Leeuwen K, Biemond BJ, Rijneveld AW, Kerkhoffs JH, Habibi A, van Bruggen R, Kuijpers TW, van der Schoot E, Pirenne F, Fijnvandraat K, Tanck MW, van den Berg TK (2019) Identification of genetic biomarkers for alloimmunization in sickle cell disease. Br J Haematol 186:887\u2013899","journal-title":"Br J Haematol"},{"key":"1_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100794","volume":"48","author":"JJ Gerritsma","year":"2021","unstructured":"Gerritsma JJ, Oomen I, Meinderts S, van der Schoot CE, Biemond BJ, van der Bom JG, Fijnvandraat K, S. consortium (2021) Back to base pairs: what is the genetic risk for red bloodcell alloimmunization? Blood Rev 48:100794","journal-title":"Blood Rev"},{"key":"1_CR130","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/jha2.270","volume":"2","author":"E Madany","year":"2021","unstructured":"Madany E, Lee J, Halprin C, Seo J, Baca N, Majlessipour F, Hendrickson JE, Pepkowitz SH, Hayes C, Klapper E, Gibb DR (2021) Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease. EJHaem 2:700\u2013710","journal-title":"EJHaem"},{"key":"1_CR131","doi-asserted-by":"publisher","first-page":"991","DOI":"10.4049\/jimmunol.2100784","volume":"208","author":"A Soldatenko","year":"2022","unstructured":"Soldatenko A, Hoyt LR, Xu L, Calabro S, Lewis SM, Gallman AE, Hudson KE, Stowell SR, Luckey CJ, Zimring JC, Liu D, Santhanakrishnan M, Hendrickson JE, Eisenbarth SC (2022) Innate and adaptive immunity to transfused allogeneic RBCs in mice requires MyD88. J Immunol 208:991\u2013997","journal-title":"J Immunol"},{"key":"1_CR132","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3324\/haematol.2023.282815","volume":"108","author":"TA Thomas","year":"2023","unstructured":"Thomas TA, Qiu A, Kim CY, Gordy DE, Miller A, Tredicine M, Dzieciatkowska M, Dei Zotti F, Hod EA, D'Alessandro A, Zimring JC, Spitalnik SL, Hudson KE (2023) Reticulocytes in donor blood units enhance red blood cell alloimmunization. Haematologica 108:2639\u20132651","journal-title":"Haematologica"},{"key":"1_CR133","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1182\/blood.2024026109","volume":"145","author":"A D'Alessandro","year":"2025","unstructured":"D'Alessandro A, Keele GR, Hay A, Nemkov T, Earley EJ, Stephenson D, Vincent M, Deng X, Stone M, Dzieciatkowska M, Hansen KC, Kleinman S, Spitalnik SL, Roubinian N, Norris PJ, Busch MP, Page GP, Stockwell BR, Churchill GA, Zimring JC (2025) Ferroptosis regulates hemolysis in stored murine and human red blood cells. Blood 145:765\u2013783","journal-title":"Blood"},{"key":"1_CR134","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1111\/trf.17960","volume":"64","author":"JC Zimring","year":"2024","unstructured":"Zimring JC, Hay AM, Dzieciatkowska M, D'Alessandro A (2024) Molecular communication between red blood cells of different phenotypes during blood storage in mice. Transfusion 64:1762\u20131771","journal-title":"Transfusion"},{"key":"1_CR135","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1182\/blood.2024023983","volume":"143","author":"T Nemkov","year":"2024","unstructured":"Nemkov T, Key A, Stephenson D, Earley EJ, Keele GR, Hay A, Amireault P, Casimir M, Dussiot M, Dzieciatkowska M, Reisz JA, Deng X, Stone M, Kleinman S, Spitalnik SL, Hansen KC, Norris PJ, Churchill GA, Busch MP, Roubinian N, Page GP, Zimring JC, Arduini A, D'Alessandro A (2024) Genetic regulation of carnitine metabolism controls lipid damage repair and aging RBC hemolysis in vivo and in vitro. Blood 143:2517\u20132533","journal-title":"Blood"},{"key":"1_CR136","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1182\/blood.2023022052","volume":"143","author":"T Nemkov","year":"2024","unstructured":"Nemkov T, Stephenson D, Erickson C, Dzieciatkowska M, Key A, Moore A, Earley EJ, Page GP, Lacroix IS, Stone M, Deng X, Raife T, Kleinman S, Zimring JC, Roubinian N, Hansen KC, Busch MP, Norris PJ, D'Alessandro A (2024) Regulation of kynurenine metabolism by blood donor genetics and biology impacts red cell hemolysis in vitro and in vivo. Blood 143:456\u2013472","journal-title":"Blood"},{"key":"1_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2020.102778","volume":"59","author":"R Balbuena-Merle","year":"2020","unstructured":"Balbuena-Merle R, Santhanakrishnan M, Devine L, Gibb DR, Tormey CA, Siddon AJ, Curtis SA, Gallagher PG, Weinstein JS, Hendrickson JE (2020) Characterization of circulating and cultured Tfh-like cells in sickle cell disease in relation to red blood cell alloimmunization status. Transfus Apher Sci 59:102778","journal-title":"Transfus Apher Sci"},{"key":"1_CR138","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bjh.17480","volume":"194","author":"M Tamagne","year":"2021","unstructured":"Tamagne M, Pakdaman S, Bartolucci P, Habibi A, Galacteros F, Pirenne F, Vingert B (2021) Whole-blood CCR7 expression and chemoattraction in red blood cell alloimmunization. Br J Haematol 194:477\u2013481","journal-title":"Br J Haematol"},{"key":"1_CR139","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1182\/bloodadvances.2020003537","volume":"5","author":"M Tamagne","year":"2021","unstructured":"Tamagne M, Pakdaman S, Bartolucci P, Habibi A, Galacteros F, Pirenne F, Vingert B (2021) Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients. Blood Adv 5:1278\u20131282","journal-title":"Blood Adv"},{"key":"1_CR140","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/eji.201445187","volume":"45","author":"B Vingert","year":"2015","unstructured":"Vingert B, Tamagne M, Habibi A, Pakdaman S, Ripa J, Elayeb R, Galacteros F, Bierling P, Ansart-Pirenne H, Bartolucci P, Noizat-Pirenne F (2015) Phenotypic differences of CD4 (+) T cells in response to red blood cell immunization in transfused sickle cell disease patients. Eur J Immunol 45:1868\u20131879","journal-title":"Eur J Immunol"},{"key":"1_CR141","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/ajh.22167","volume":"86","author":"W Bao","year":"2011","unstructured":"Bao W, Zhong H, Li X, Lee MT, Schwartz J, Sheth S, Yazdanbakhsh K (2011) Immune regulation in chronically transfused Allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major. Am J Hematol 86:1001\u20131006","journal-title":"Am J Hematol"},{"key":"1_CR142","doi-asserted-by":"crossref","unstructured":"Liu Y, Su S, Shayo S, Bao W, Pal M, Dou K, Shi PA, Aygun B, Campbell-Lee S, Lobo CA, Mendelson A, An X, Manwani D, Zhong H, Yazdanbakhsh K (2023) Hemolysis dictates monocyte differentiation via two distinct pathways in sickle cell disease vaso-occlusion. J Clin Invest 133","DOI":"10.1172\/JCI172087"},{"key":"1_CR143","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1182\/blood.2020008511","volume":"137","author":"M Pal","year":"2021","unstructured":"Pal M, Bao W, Wang R, Liu Y, An X, Mitchell WB, Lobo CA, Minniti C, Shi PA, Manwani D, Yazdanbakhsh K, Zhong H (2021) Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease. Blood 137:269\u2013280","journal-title":"Blood"},{"key":"1_CR144","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3324\/haematol.2015.132738","volume":"100","author":"E Godefroy","year":"2015","unstructured":"Godefroy E, Zhong H, Pham P, Friedman D, Yazdanbakhsh K (2015) TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization. Haematologica 100:1415\u20131425","journal-title":"Haematologica"},{"key":"1_CR145","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3324\/haematol.2016.147181","volume":"101","author":"E Godefroy","year":"2016","unstructured":"Godefroy E, Liu Y, Shi P, Mitchell WB, Cohen D, Chou ST, Manwani D, Yazdanbakhsh K (2016) Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization. Haematologica 101:1028\u20131038","journal-title":"Haematologica"},{"key":"1_CR146","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4049\/jimmunol.1400105","volume":"193","author":"H Zhong","year":"2014","unstructured":"Zhong H, Bao W, Friedman D, Yazdanbakhsh K (2014) Hemin controls T cell polarization in sickle cell alloimmunization. J Immunol 193:102\u2013110","journal-title":"J Immunol"},{"key":"1_CR147","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.1182\/blood-2008-12-193748","volume":"113","author":"W Bao","year":"2009","unstructured":"Bao W, Yu J, Heck S, Yazdanbakhsh K (2009) Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood 113:5624\u20135627","journal-title":"Blood"},{"key":"1_CR148","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ajh.20959","volume":"82","author":"J Yu","year":"2007","unstructured":"Yu J, Heck S, Yazdanbakhsh K (2007) Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol 82:691\u2013696","journal-title":"Am J Hematol"},{"key":"1_CR149","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/ajh.23488","volume":"88","author":"W Bao","year":"2013","unstructured":"Bao W, Zhong H, Manwani D, Vasovic L, Uehlinger J, Lee MT, Sheth S, Shi P, Yazdanbakhsh K (2013) Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease. Am J Hematol 88:736\u2013740","journal-title":"Am J Hematol"},{"key":"1_CR150","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/bjh.18899","volume":"202","author":"H Nakahara","year":"2023","unstructured":"Nakahara H, Cheedarla N, Verkerke HP, Cheedarla S, Wu SC, Hendrickson JE, Chang A, McLemore ML, El Rassi F, Roback JD, Neish AS, Fasano RM, Stowell SR (2023) Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease. Br J Haematol 202:937\u2013941","journal-title":"Br J Haematol"},{"key":"1_CR151","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.2020009210","volume":"139","author":"CM Arthur","year":"2022","unstructured":"Arthur CM, Zerra PE, Shin S, Wang J, Song X, Doering CB, Lollar P, Meeks S, Stowell SR (2022) Nonhuman glycans can regulate anti-factor VIII antibody formation in mice. Blood 139:1312\u20131317","journal-title":"Blood"},{"key":"1_CR152","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1046\/j.1538-7836.2003.00230.x","volume":"1","author":"A Sharathkumar","year":"2003","unstructured":"Sharathkumar A, Lillicrap D, Blanchette VS, Kern M, Leggo J, Stain AM, Brooker L, Carcao MD (2003) Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia a. J Thromb Haemost 1:1228\u20131236","journal-title":"J Thromb Haemost"},{"key":"1_CR153","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/j.1538-7836.2011.04467.x","volume":"9","author":"CL Eckhardt","year":"2011","unstructured":"Eckhardt CL, van der Bom JG, van der Naald M, Peters M, Kamphuisen PW, Fijnvandraat K (2011) Surgery and inhibitor development in hemophilia a: a systematic review. J Thromb Haemost 9:1948\u20131958","journal-title":"J Thromb Haemost"},{"key":"1_CR154","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.hoc.2016.01.008","volume":"30","author":"SK Forest","year":"2016","unstructured":"Forest SK, Hod EA (2016) Management of the Platelet Refractory Patient. Hematol Oncol Clin North Am 30:665\u2013677","journal-title":"Hematol Oncol Clin North Am"},{"key":"1_CR155","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","volume":"142","author":"E Hod","year":"2008","unstructured":"Hod E, Schwartz J (2008) Platelet transfusion refractoriness. Br J Haematol 142:348\u2013360","journal-title":"Br J Haematol"},{"key":"1_CR156","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2015-10-673426","volume":"127","author":"CM Arthur","year":"2016","unstructured":"Arthur CM, Patel SR, Sullivan HC, Winkler AM, Tormey CA, Hendrickson JE, Stowell SR (2016) CD8+ T cells mediate antibody-independent platelet clearance in mice. Blood 127:1823\u20131827","journal-title":"Blood"},{"key":"1_CR157","doi-asserted-by":"crossref","unstructured":"Lewis SM, Williams A, Eisenbarth SC (2019) Structure and function of the immune system in the spleen. Sci Immunol 4","DOI":"10.1126\/sciimmunol.aau6085"},{"key":"1_CR158","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/gutjnl-2014-307916","volume":"65","author":"ER Mann","year":"2016","unstructured":"Mann ER, Bernardo D, English NR, Landy J, Al-Hassi HO, Peake ST, Man R, Elliott TR, Spranger H, Lee GH, Parian A, Brant SR, Lazarev M, Hart AL, Li X, Knight SC (2016) Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum. Gut 65:256\u2013270","journal-title":"Gut"},{"key":"1_CR159","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1046\/j.1365-2249.1998.00657.x","volume":"113","author":"A Klemm","year":"1998","unstructured":"Klemm A, Tschernig T, Krug N, Pabst R (1998) Lymphocyte subsets in distinct lung compartments show a different ability to produce interferon-gamma (IFN-gamma) during a pulmonary immune response. Clin Exp Immunol 113:252\u2013257","journal-title":"Clin Exp Immunol"},{"key":"1_CR160","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5:606\u2013616","journal-title":"Nat Rev Immunol"},{"key":"1_CR161","doi-asserted-by":"publisher","first-page":"803","DOI":"10.4049\/jimmunol.172.2.803","volume":"172","author":"K Attanavanich","year":"2004","unstructured":"Attanavanich K, Kearney JF (2004) Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 172:803\u2013811","journal-title":"J Immunol"},{"key":"1_CR162","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri3383","volume":"13","author":"A Cerutti","year":"2013","unstructured":"Cerutti A, Cols M, Puga I (2013) Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 13:118\u2013132","journal-title":"Nat Rev Immunol"},{"key":"1_CR163","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217607120","volume":"120","author":"Y Qiang","year":"2023","unstructured":"Qiang Y, Sissoko A, Liu ZL, Dong T, Zheng F, Kong F, Higgins JM, Karniadakis GE, Buffet PA, Suresh S, Dao M (2023) Microfluidic study of retention and elimination of abnormal red blood cells by human spleen with implications for sickle cell disease. Proc Natl Acad Sci USA 120:e2217607120","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103241","volume":"9","author":"G Goyal","year":"2022","unstructured":"Goyal G, Prabhala P, Mahajan G, Bausk B, Gilboa T, Xie L, Zhai Y, Lazarovits R, Mansour A, Kim MS, Patil A, Curran D, Long JM, Sharma S, Junaid A, Cohen L, Ferrante TC, Levy O, Prantil-Baun R, Walt DR, Ingber DE (2022) Ectopic lymphoid follicle formation and human seasonal influenza vaccination responses recapitulated in an organ-on-a-Chip. Adv Sci (Weinh) 9:e2103241","journal-title":"Adv Sci (Weinh)"},{"key":"1_CR165","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/j.semperi.2012.04.005","volume":"36","author":"A Doctor","year":"2012","unstructured":"Doctor A, Spinella P (2012) Effect of processing and storage on red blood cell function in vivo. Semin Perinatol 36:248\u2013259","journal-title":"Semin Perinatol"},{"key":"1_CR166","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1423-0410.2010.01327.x","volume":"99","author":"EA Hod","year":"2010","unstructured":"Hod EA, Arinsburg SA, Francis RO, Hendrickson JE, Zimring JC, Spitalnik SL (2010) Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sang 99:99\u2013111","journal-title":"Vox Sang"},{"key":"1_CR167","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/MOH.0b013e328311f40a","volume":"15","author":"EA Hod","year":"2008","unstructured":"Hod EA, Zimring JC, Spitalnik SL (2008) Lessons learned from mouse models of hemolytic transfusion reactions. Curr Opin Hematol 15:601\u2013605","journal-title":"Curr Opin Hematol"},{"key":"1_CR168","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tmrv.2006.08.005","volume":"21","author":"JD Roback","year":"2007","unstructured":"Roback JD, Su L, Zimring JC, Hillyer CD (2007) Transfusion-transmitted cytomegalovirus: lessons from a murine model. Transfus Med Rev 21:26\u201336","journal-title":"Transfus Med Rev"},{"key":"1_CR169","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1365-2141.2002.03675.x","volume":"119","author":"NC Hughes-Jones","year":"2002","unstructured":"Hughes-Jones NC, Gardner B (2002) Red cell agglutination: the first description by Creite (1869) and further observations made by Landois (1875) and Landsteiner (1901). Br J Haematol 119:889\u2013893","journal-title":"Br J Haematol"},{"key":"1_CR170","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/bfgp\/elp010","volume":"8","author":"C Vandiedonck","year":"2009","unstructured":"Vandiedonck C, Knight JC (2009) The human major histocompatibility complex as a paradigm in genomics research. Brief Funct Genomic Proteomic 8:379\u2013394","journal-title":"Brief Funct Genomic Proteomic"},{"key":"1_CR171","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/248701a0","volume":"248","author":"RM Zinkernagel","year":"1974","unstructured":"Zinkernagel RM, Doherty PC (1974) Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248:701\u2013702","journal-title":"Nature"},{"key":"1_CR172","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1172\/JCI104970","volume":"43","author":"RH Aster","year":"1964","unstructured":"Aster RH, Jandl JH (1964) Platelet Sequestration in Man. I Methods. J Clin Invest 43:843\u2013855","journal-title":"J Clin Invest"},{"key":"1_CR173","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1172\/JCI104971","volume":"43","author":"RH Aster","year":"1964","unstructured":"Aster RH, Jandl JH (1964) Platelet sequestration in Man. Ii. immunological and clinical studies. J Clin Invest 43:856\u2013869","journal-title":"J Clin Invest"},{"key":"1_CR174","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJM196904032801401","volume":"280","author":"R Patel","year":"1969","unstructured":"Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735\u2013739","journal-title":"N Engl J Med"},{"key":"1_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103677","volume":"23","author":"Q Li","year":"2024","unstructured":"Li Q, Marcoux G, Hu Y, Rebetz J, Guo L, Semple E, Provan D, Xu S, Hou M, Peng J, Semple JW (2024) Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP). Autoimmun Rev 23:103677","journal-title":"Autoimmun Rev"},{"key":"1_CR176","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1016\/j.jtha.2024.08.003","volume":"22","author":"K Johansson","year":"2024","unstructured":"Johansson K, Maouia A, Rebetz J, Marcoux G, Shannon O, Italiano JE Jr, Narayanan P, Henry S, Shen L, Semple JW (2024) CpG oligonucleotides induce acute murine thrombocytopenia dependent on toll-like receptor 9 and spleen tyrosine kinase pathways. J Thromb Haemost 22:3266\u20133276","journal-title":"J Thromb Haemost"},{"key":"1_CR177","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/bjh.19079","volume":"203","author":"K Yazdanbakhsh","year":"2023","unstructured":"Yazdanbakhsh K, Provan D, Semple JW (2023) The role of T cells and myeloid-derived suppressor cells in refractory immune thrombocytopenia. Br J Haematol 203:54\u201361","journal-title":"Br J Haematol"},{"key":"1_CR178","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/bjh.18784","volume":"201","author":"R Kapur","year":"2023","unstructured":"Kapur R, Semple JW (2023) Binge-reading on immune thrombocytopenia: everything you ever wanted to know. Br J Haematol 201:811\u2013812","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"1_CR179","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00277-009-0882-8","volume":"89","author":"JW Semple","year":"2010","unstructured":"Semple JW (2010) Animal models of immune thrombocytopenia (ITP). Ann Hematol 89(Suppl 1):37\u201344","journal-title":"Ann Hematol"},{"key":"1_CR180","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/10408363.2016.1200008","volume":"53","author":"XR Xu","year":"2016","unstructured":"Xu XR, Zhang D, Oswald BE, Carrim N, Wang X, Hou Y, Zhang Q, Lavalle C, McKeown T, Marshall AH, Ni H (2016) Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci 53:409\u2013430","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1_CR181","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nri2956","volume":"11","author":"JW Semple","year":"2011","unstructured":"Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264\u2013274","journal-title":"Nat Rev Immunol"},{"key":"1_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101252","volume":"69","author":"JM Schoenaker","year":"2025","unstructured":"Schoenaker JM, Nelson VS, Henderickx JGE, Terveer EM, Jansen AJG, Porcelijn L, Netelenbos T, Schipperus MR, Kapur R (2025) The intestinal flora: the key to unraveling heterogeneity in immune thrombocytopenia? Blood Rev 69:101252","journal-title":"Blood Rev"},{"key":"1_CR183","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/384685","volume":"2012","author":"C Li","year":"2012","unstructured":"Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, Chen P, Ni H (2012) Crosstalk between platelets and the immune system: old systems with New discoveries. Adv Hematol 2012:2012, 384685","journal-title":"Adv Hematol"},{"key":"1_CR184","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1182\/bloodadvances.2023012155","volume":"8","author":"L Gil Gonzalez","year":"2024","unstructured":"Gil Gonzalez L, Won KD, Tawhidi Z, Cummins E, Cruz-Leal Y, Tundidor Cabado Y, Sachs UJ, Norris PAA, Shan Y, Bhakta V, Li J, Samudio I, Silva-Moreno B, Cerna-Portillo L, Pavon Oro A, Bergqvist P, Chan P, Moorehead A, Sholzberg M, Sheffield WP, Lazarus AH (2024) Human fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP. Blood Adv 8:1869\u20131879","journal-title":"Blood Adv"},{"key":"1_CR185","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1182\/blood.2019003646","volume":"135","author":"R Khan","year":"2020","unstructured":"Khan R, Menard M, Jen CC, Chen X, Norris PAA, Lazarus AH (2020) Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP. Blood 135:2420\u20132424","journal-title":"Blood"},{"key":"1_CR186","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41467-017-00269-1","volume":"8","author":"I Yougbare","year":"2017","unstructured":"Yougbare I, Tai WS, Zdravic D, Oswald BE, Lang S, Zhu G, Leong-Poi H, Qu D, Yu L, Dunk C, Zhang J, Sled JG, Lye SJ, Brkic J, Peng C, Hoglund P, Croy BA, Adamson SL, Wen XY, Stewart DJ, Freedman J, Ni H (2017) Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia. Nat Commun 8:224","journal-title":"Nat Commun"},{"key":"1_CR187","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.gendis.2015.02.003","volume":"2","author":"B Vadasz","year":"2015","unstructured":"Vadasz B, Chen P, Yougbare I, Zdravic D, Li J, Li C, Carrim N, Ni H (2015) Platelets and platelet alloantigens: lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia. Genes Dis 2:173\u2013185","journal-title":"Genes Dis"},{"key":"1_CR188","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1160\/TH13-04-0354","volume":"110","author":"C Li","year":"2013","unstructured":"Li C, Chen P, Vadasz B, Ma L, Zhou H, Lang S, Freedman J, Ni H (2013) Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia. Thromb Haemost 110:1250\u20131258","journal-title":"Thromb Haemost"},{"key":"1_CR189","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1182\/blood-2015-10-675751","volume":"127","author":"N Zhang","year":"2016","unstructured":"Zhang N, Zhi H, Curtis BR, Rao S, Jobaliya C, Poncz M, French DL, Newman PJ (2016) CRISPR\/Cas9-mediated conversion of human platelet alloantigen allotypes. Blood 127:675\u2013680","journal-title":"Blood"},{"key":"1_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.111172","volume":"85","author":"DK Newman","year":"2024","unstructured":"Newman DK, Newman PJ (2024) Antigen-specific immunotherapy for platelet alloimmune disorders. Hum Immunol 85:111172","journal-title":"Hum Immunol"},{"key":"1_CR191","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2249.2005.02663.x","volume":"139","author":"AR Youssef","year":"2005","unstructured":"Youssef AR, Shen CR, Lin CL, Barker RN, Elson CJ (2005) IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice. Clin Exp Immunol 139:84\u201389","journal-title":"Clin Exp Immunol"},{"key":"1_CR192","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/MOH.0000000000000459","volume":"25","author":"HL Howie","year":"2018","unstructured":"Howie HL, Hudson KE (2018) Murine models of autoimmune hemolytic anemia. Curr Opin Hematol 25:473\u2013481","journal-title":"Curr Opin Hematol"},{"key":"1_CR193","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3324\/haematol.2012.065144","volume":"97","author":"KE Hudson","year":"2012","unstructured":"Hudson KE, Hendrickson JE, Cadwell CM, Iwakoshi NN, Zimring JC (2012) Partial tolerance of autoreactive B and T cells to erythrocyte-specific self-antigens in mice. Haematologica 97:1836\u20131844","journal-title":"Haematologica"},{"key":"1_CR194","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fimmu.2016.00348","volume":"7","author":"AL Richards","year":"2016","unstructured":"Richards AL, Kapp LM, Wang X, Howie HL, Hudson KE (2016) Regulatory T cells are dispensable for tolerance to RBC antigens. Front Immunol 7:348","journal-title":"Front Immunol"},{"key":"1_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102489","volume":"114","author":"ASL Wong","year":"2020","unstructured":"Wong ASL, Gruber DR, Richards AL, Sheldon K, Qiu A, Hay A, Hudson KE (2020) Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity. J Autoimmun 114:102489","journal-title":"J Autoimmun"},{"key":"1_CR196","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/trf.16191","volume":"61","author":"AL Richards","year":"2021","unstructured":"Richards AL, Qiu A, Zotti FD, Sheldon K, Usaneerungrueng C, Gruber DR, Hudson KE (2021) Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity. Transfusion 61:225\u2013235","journal-title":"Transfusion"},{"key":"1_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.752330","volume":"12","author":"F Dei Zotti","year":"2021","unstructured":"Dei Zotti F, Qiu A, La Carpia F, Moriconi C, Hudson KE (2021) A New murine model of primary autoimmune hemolytic anemia (AIHA). Front Immunol 12:752330","journal-title":"Front Immunol"},{"key":"1_CR198","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1182\/blood.2024024230","volume":"144","author":"F Dei Zotti","year":"2024","unstructured":"Dei Zotti F, Qiu A, D'Agati VD, Jagnarine S, Kyritsis E, Miller A, Tredicine M, Fliginger D, Stone EF, Panch S, Hudson KE (2024) Mitigation of checkpoint inhibitor-induced autoimmune hemolytic anemia through modulation of purinergic signaling. Blood 144:1581\u20131594","journal-title":"Blood"},{"key":"1_CR199","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1182\/blood.2024025010","volume":"145","author":"W Zhu","year":"2024","unstructured":"Zhu W, Zheng Y, Yu M, Witman N, Zhou L, Wei J, Zhang Y, Topchyan P, Nguyen C, Wang D, Janecke R, Padmanabhan A, Baumann Kreuziger L, White GC, Hari P, Gu T, Fields AT, Kornblith L, Aster RH, Zhu J, Cui W, Jobe SM, Graham MB, Wang D, Wen R (2024) Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19. Blood 145:635\u2013647","journal-title":"Blood"},{"key":"1_CR200","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1182\/blood.2022017612","volume":"141","author":"W Zhu","year":"2023","unstructured":"Zhu W, Zheng Y, Yu M, Wu Y, Wei J, Zhou L, Fu G, Schneider N, Jones C, Irani M, Padmanabhan A, Aster R, Wang D, Wen R (2023) Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis. Blood 141:1060\u20131069","journal-title":"Blood"},{"key":"1_CR201","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1182\/blood.2021014588","volume":"140","author":"AJ Kanack","year":"2022","unstructured":"Kanack AJ, Bayas A, George G, Abou-Ismail MY, Singh B, Kohlhagen MC, Splinter NP, Christ M, Naumann M, Moser KA, Smock KJ, Grazioli A, Wen R, Wang D, Murray DL, Padmanabhan A (2022) Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT. Blood 140:73\u201377","journal-title":"Blood"},{"key":"1_CR202","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.4049\/jimmunol.1900196","volume":"203","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Zhu W, Haribhai D, Williams CB, Aster RH, Wen R, Wang D (2019) Regulatory T cells control PF4\/heparin antibody production in mice. J Immunol 203:1786\u20131792","journal-title":"J Immunol"},{"key":"1_CR203","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.chest.2016.02.641","volume":"150","author":"A Padmanabhan","year":"2016","unstructured":"Padmanabhan A, Jones CG, Curtis BR, Bougie DW, Sullivan MJ, Peswani N, McFarland JG, Eastwood D, Wang D, Aster RH (2016) A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia\/thrombosis. Chest 150:506\u2013515","journal-title":"Chest"},{"key":"1_CR204","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1182\/blood-2014-09-603464","volume":"125","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Yu M, Padmanabhan A, Aster RH, Yuan L, Wen R, Wang D (2015) Critical role of CD4 T cells in PF4\/heparin antibody production in mice. Blood 125:1826\u20131829","journal-title":"Blood"},{"key":"1_CR205","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1182\/blood-2013-11-540781","volume":"123","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Wang AW, Yu M, Padmanabhan A, Tourdot BE, Newman DK, White GC, Aster RH, Wen R, Wang D (2014) B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia. Blood 123:931\u2013934","journal-title":"Blood"},{"key":"1_CR206","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2013-01-477091","volume":"121","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Yu M, Podd A, Yuan L, Newman DK, Wen R, Arepally G, Wang D (2013) Critical role for mouse marginal zone B cells in PF4\/heparin antibody production. Blood 121:3484\u20133492","journal-title":"Blood"},{"key":"1_CR207","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1182\/blood-2014-06-580894","volume":"125","author":"A Padmanabhan","year":"2015","unstructured":"Padmanabhan A, Jones CG, Bougie DW, Curtis BR, McFarland JG, Wang D, Aster RH (2015) Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis. Blood 125:155\u2013161","journal-title":"Blood"},{"key":"1_CR208","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.jtha.2024.12.021","volume":"23","author":"CL Maier","year":"2025","unstructured":"Maier CL, Nakahara H, Barker NA, Auld SC, Truong AD, Friend S, Caridi-Scheible M, Connor M, Gaddh M, Cobb J, Polly DM, Guarner J, Powell C, Kempton CL, Daniels L, Wynn AT, Sniecinski R, Duncan A, Roback J, Masud T, Conlon S, Wade J, Wong A, Verkerke H, Zerra PE, Butler H, Sullivan HC, Easley KA, Josephson CD, Stowell SR (2025) Therapeutic plasma exchange for fibrinogen-associated hyperviscosity: results of the COVID-19 PLasma EXchange (COPLEX) randomized controlled trial. J Thromb Haemost 23:1393\u20131400","journal-title":"J Thromb Haemost"},{"key":"1_CR209","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1182\/blood.2023020484","volume":"143","author":"S van der Velden","year":"2024","unstructured":"van der Velden S, van Osch TLJ, Seghier A, Bentlage AEH, Mok JY, Geerdes DM, van Esch WJE, Pouw RB, Brouwer MC, Jongerius I, de Haas M, Porcelijn L, van der Schoot CE, Vidarsson G, Kapur R (2024) Complement activation drives antibody-mediated transfusion-related acute lung injury via macrophage trafficking and formation of NETs. Blood 143:79\u201391","journal-title":"Blood"},{"key":"1_CR210","doi-asserted-by":"crossref","unstructured":"Cleary SJ, Seo Y, Tian JJ, Kwaan N, Bulkley DP, Bentlage AE, Vidarsson G, Boilard E, Spirig R, Zimring JC, Looney MR (2024) IgG hexamers initiate complement-dependent acute lung injury. J Clin Invest 134","DOI":"10.1172\/JCI178351"},{"key":"1_CR211","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1172\/JCI138136","volume":"130","author":"SJ Cleary","year":"2020","unstructured":"Cleary SJ, Kwaan N, Tian JJ, Calabrese DR, Mallavia B, Magnen M, Greenland JR, Urisman A, Singer JP, Hays SR, Kukreja J, Hay AM, Howie HL, Toy P, Lowell CA, Morrell CN, Zimring JC, Looney MR (2020) Complement activation on endothelium initiates antibody-mediated acute lung injury. J Clin Invest 130:5909\u20135923","journal-title":"J Clin Invest"},{"key":"1_CR212","doi-asserted-by":"crossref","unstructured":"Ortiz-Munoz G, Looney MR (2015) Two-event transfusion-related acute lung injury mouse model. Bio Protoc 5","DOI":"10.21769\/BioProtoc.1505"},{"key":"1_CR213","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1172\/JCI61303","volume":"122","author":"A Caudrillier","year":"2012","unstructured":"Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, Toy P, Werb Z, Looney MR (2012) Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 122:2661\u20132671","journal-title":"J Clin Invest"},{"key":"1_CR214","first-page":"3450","volume":"119","author":"MR Looney","year":"2009","unstructured":"Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA (2009) Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 119:3450\u20133461","journal-title":"J Clin Invest"},{"key":"1_CR215","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1111\/j.1537-2995.2011.03186.x","volume":"51","author":"CC Silliman","year":"2011","unstructured":"Silliman CC, Moore EE, Kelher MR, Khan SY, Gellar L, Elzi DJ (2011) Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 51:2549\u20132554","journal-title":"Transfusion"},{"key":"1_CR216","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.tmrv.2008.09.002","volume":"23","author":"LE Logdberg","year":"2009","unstructured":"Logdberg LE, Vikulina T, Zimring JC, Hillyer CD (2009) Animal models of transfusion-related acute lung injury. Transfus Med Rev 23:13\u201324","journal-title":"Transfus Med Rev"},{"key":"1_CR217","first-page":"443","volume":"20","author":"SF van Wonderen","year":"2022","unstructured":"van Wonderen SF, Klanderman RB, Vlaar APJ (2022) Understanding transfusion-related acute lung injury (TRALI) and its complex pathophysiology. Blood Transfus 20:443\u2013445","journal-title":"Blood Transfus"},{"key":"1_CR218","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1182\/blood-2010-04-278135","volume":"117","author":"BH Shaz","year":"2011","unstructured":"Shaz BH, Stowell SR, Hillyer CD (2011) Transfusion-related acute lung injury: from bedside to bench and back. Blood 117:1463\u20131471","journal-title":"Blood"},{"key":"1_CR219","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/bloodadvances.2022008936","volume":"7","author":"A Hay","year":"2023","unstructured":"Hay A, Nemkov T, Gamboni F, Dzieciatkowska M, Key A, Galbraith M, Bartsch K, Sun K, Xia Y, Stone M, Busch MP, Norris PJ, Zimring JC, D'Alessandro A (2023) Sphingosine 1-phosphate has a negative effect on RBC storage quality. Blood Adv 7:1379\u20131393","journal-title":"Blood Adv"},{"key":"1_CR220","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1182\/bloodadvances.2019000605","volume":"3","author":"HL Howie","year":"2019","unstructured":"Howie HL, Hay AM, de Wolski K, Waterman H, Lebedev J, Fu X, Culp-Hill R, D'Alessandro A, Gorham JD, Ranson MS, Roback JD, Thomson PC, Zimring JC (2019) Differences in Steap3 expression are a mechanism of genetic variation of RBC storage and oxidative damage in mice. Blood Adv 3:2272\u20132285","journal-title":"Blood Adv"},{"key":"1_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102646","volume":"96","author":"A D'Alessandro","year":"2025","unstructured":"D'Alessandro A, Zimring JC (2025) From metabolomics to transfusion-associated immunomodulation. Curr Opin Immunol 96:102646","journal-title":"Curr Opin Immunol"},{"key":"1_CR222","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/jpet.124.002218","volume":"391","author":"KH Dziewulska-Cronk","year":"2024","unstructured":"Dziewulska-Cronk KH, Reisz JA, Hay AM, Nemkov T, Cendali FI, Issaian A, Lamb DR, Palha MS, Legenzov EA, Kao JPY, Walker LA, Tekwani BL, Buehler PW, D'Alessandro A, Zimring JC (2024) Primaquine-5,6-Orthoquinone is directly hemolytic to older G6PD deficient RBCs in a humanized mouse model. J Pharmacol Exp Ther 391:119\u2013129","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR223","doi-asserted-by":"crossref","unstructured":"D'Alessandro A, Anastasiadi AT, Tzounakas VL, Nemkov T, Reisz JA, Kriebardis AG, Zimring JC, Spitalnik SL, Busch MP (2023) Red blood cell metabolism in vivo and in vitro. Meta 13","DOI":"10.3390\/metabo13070793"},{"key":"1_CR224","first-page":"50","volume":"21","author":"A Hay","year":"2023","unstructured":"Hay A, Dziewulska K, Gamboni F, Nerguizian D, Dzieciatkowska M, Zimring JC, D'Alessandro A (2023) Hypoxic storage of murine red blood cells improves energy metabolism and post-transfusion recoveries. Blood Transfus 21:50\u201361","journal-title":"Blood Transfus"},{"key":"1_CR225","doi-asserted-by":"crossref","unstructured":"D'Alessandro A, Howie HL, Hay AM, Dziewulska KH, Brown BC, Wither MJ, Karafin M, Stone EF, Spitalnik SL, Hod EA, Francis RO, Fu X, Thomas T, Zimring JC (2021) Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice. JCI Insight 6","DOI":"10.1172\/jci.insight.147056"},{"key":"1_CR226","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3324\/haematol.2017.178608","volume":"103","author":"T Nemkov","year":"2018","unstructured":"Nemkov T, Sun K, Reisz JA, Song A, Yoshida T, Dunham A, Wither MJ, Francis RO, Roach RC, Dzieciatkowska M, Rogers SC, Doctor A, Kriebardis A, Antonelou M, Papassideri I, Young CT, Thomas TA, Hansen KC, Spitalnik SL, Xia Y, Zimring JC, Hod EA, D'Alessandro A (2018) Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage. Haematologica 103:361\u2013372","journal-title":"Haematologica"},{"key":"1_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101336","volume":"4","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Markmann C, Yu M, Agarwal D, Rostami S, Wang W, Liu C, Zhao H, Ochoa T, Parvathaneni K, Xu X, Li E, Gonzalez V, Khadka R, Hoffmann J, Knox JJ, Scholler J, Marcellus B, Allman D, Fraietta JA, Samelson-Jones B, Milone MC, Monos D, Garfall AL, Naji A, Bhoj VG (2023) Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific Allo-antibodies. Cell Rep Med 4:101336","journal-title":"Cell Rep Med"},{"key":"1_CR228","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1182\/blood.2022016376","volume":"140","author":"AM Webber","year":"2022","unstructured":"Webber AM, Bradstreet TR, Wang X, Guo H, Nelson CA, Fremont DH, Edelson BT, Liu C (2022) Antigen-guided depletion of anti-HLA antibody-producing cells by HLA-fc fusion proteins. Blood 140:1803\u20131815","journal-title":"Blood"},{"key":"1_CR229","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/MOH.0000000000000662","volume":"28","author":"A Tang","year":"2021","unstructured":"Tang A, Mendelson A (2021) Recent lessons learned for ex-vivo platelet production. Curr Opin Hematol 28:424\u2013430","journal-title":"Curr Opin Hematol"},{"key":"1_CR230","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5966\/sctm.2013-0054","volume":"3","author":"S Shah","year":"2014","unstructured":"Shah S, Huang X, Cheng L (2014) Concise review: stem cell-based approaches to red blood cell production for transfusion. Stem Cells Transl Med 3:346\u2013355","journal-title":"Stem Cells Transl Med"},{"key":"1_CR231","first-page":"3705","volume":"109","author":"E Olivier","year":"2024","unstructured":"Olivier E, Zhang S, Yan Z, Bouhassira EE (2024) Stem cell factor and erythropoietin-independent production of cultured reticulocytes. Haematologica 109:3705\u20133720","journal-title":"Haematologica"},{"key":"1_CR232","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/MOH.0000000000000810","volume":"31","author":"N Gunawardena","year":"2024","unstructured":"Gunawardena N, Chou ST (2024) Generation of red blood cells from induced pluripotent stem cells. Curr Opin Hematol 31:115\u2013121","journal-title":"Curr Opin Hematol"},{"key":"1_CR233","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1182\/blood.2022015883","volume":"140","author":"HH An","year":"2022","unstructured":"An HH, Gagne AL, Maguire JA, Pavani G, Abdulmalik O, Gadue P, French DL, Westhoff CM, Chou ST (2022) The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine. Blood 140:1723\u20131734","journal-title":"Blood"},{"key":"1_CR234","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ajh.26410","volume":"97","author":"J Deng","year":"2022","unstructured":"Deng J, Lancelot M, Jajosky R, Deng Q, Deeb K, Saakadze N, Gao Y, Jaye D, Liu S, Stowell SR, Cheng L, Roback JD (2022) Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient mice. Am J Hematol 97:194\u2013202","journal-title":"Am J Hematol"},{"key":"1_CR235","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1182\/blood.2023021453","volume":"144","author":"S Hegde","year":"2024","unstructured":"Hegde S, Akbar H, Wellendorf AM, Nestheide S, Johnson JF, Zhao X, Setchell KD, Zheng Y, Cancelas JA (2024) Inhibition of RHOA activity preserves the survival and hemostasis function of long-term cold-stored platelets. Blood 144:1732\u20131746","journal-title":"Blood"},{"key":"1_CR236","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/trf.15254","volume":"59","author":"CM Arthur","year":"2019","unstructured":"Arthur CM, Nalbant D, Feldman HA, Saeedi BJ, Matthews J, Robinson BS, Kamili NA, Bennett A, Cress GA, Sola-Visner M, Jones RM, Zimmerman MB, Neish AS, Patel RM, Nopoulos P, Georgieff MK, Roback JD, Widness JA, Josephson CD, Stowell SR (2019) Anemia induces gut inflammation and injury in an animal model of preterm infants. Transfusion 59:1233\u20131245","journal-title":"Transfusion"},{"key":"1_CR237","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/pr.2015.41","volume":"77","author":"DJ Wallin","year":"2015","unstructured":"Wallin DJ, Tkac I, Stucker S, Ennis KM, Sola-Visner M, Rao R, Georgieff MK (2015) Phlebotomy-induced anemia alters hippocampal neurochemistry in neonatal mice. Pediatr Res 77:765\u2013771","journal-title":"Pediatr Res"},{"key":"1_CR238","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/MOH.0000000000000736","volume":"29","author":"P Davenport","year":"2022","unstructured":"Davenport P, Sola-Visner M (2022) Immunologic effects of red blood cell and platelet transfusions in neonates. Curr Opin Hematol 29:297\u2013305","journal-title":"Curr Opin Hematol"},{"key":"1_CR239","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/trf.16895","volume":"62","author":"P Davenport","year":"2022","unstructured":"Davenport P, Fan HH, Nolton E, Feldman HA, Lorenz V, Canas J, Acosta-Zaldivar M, Yakah W, Arthur C, Martin C, Stowell S, Koehler J, Mager D, Sola-Visner M (2022) Platelet transfusions in a murine model of neonatal polymicrobial sepsis: divergent effects on inflammation and mortality. Transfusion 62:1177\u20131187","journal-title":"Transfusion"},{"key":"1_CR240","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1182\/blood-2011-09-382655","volume":"119","author":"NH Smith","year":"2012","unstructured":"Smith NH, Hod EA, Spitalnik SL, Zimring JC, Hendrickson JE (2012) Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. Blood 119:1566\u20131569","journal-title":"Blood"},{"key":"1_CR241","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/blood-2005-03-1040","volume":"106","author":"JC Zimring","year":"2005","unstructured":"Zimring JC, Hair GA, Chadwick TE, Deshpande SS, Anderson KM, Hillyer CD, Roback JD (2005) Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 106:1105\u20131112","journal-title":"Blood"},{"key":"1_CR242","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2008-01-132092","volume":"112","author":"EA Hod","year":"2008","unstructured":"Hod EA, Cadwell CM, Liepkalns JS, Zimring JC, Sokol SA, Schirmer DA, Jhang J, Spitalnik SL (2008) Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood 112:891\u2013894","journal-title":"Blood"},{"key":"1_CR243","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1182\/blood-2009-04-214387","volume":"114","author":"M Desmarets","year":"2009","unstructured":"Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC (2009) Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 114:2315\u20132322","journal-title":"Blood"},{"key":"1_CR244","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1182\/blood.V97.9.2872","volume":"97","author":"I Auffray","year":"2001","unstructured":"Auffray I, Marfatia S, de Jong K, Lee G, Huang CH, Paszty C, Tanner MJ, Mohandas N, Chasis JA (2001) Glycophorin a dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin a transgenic mice. Blood 97:2872\u20132878","journal-title":"Blood"},{"key":"1_CR245","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/353765a0","volume":"353","author":"SB Hartley","year":"1991","unstructured":"Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC (1991) Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353:765\u2013769","journal-title":"Nature"},{"key":"1_CR246","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1111\/j.1537-2995.2012.03641.x","volume":"52","author":"NH Smith","year":"2012","unstructured":"Smith NH, Henry KL, Cadwell CM, Bennett A, Hendrickson JE, Frame T, Zimring JC (2012) Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion 52:2620\u20132630","journal-title":"Transfusion"},{"key":"1_CR247","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","volume":"122","author":"SR Stowell","year":"2013","unstructured":"Stowell SR, Henry KL, Smith NH, Hudson KE, Halverson GR, Park JC, Bennett AM, Girard-Pierce KR, Arthur CM, Bunting ST, Zimring JC, Hendrickson JE (2013) Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model. Blood 122:1494\u20131504","journal-title":"Blood"},{"key":"1_CR248","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/trf.12217","volume":"54","author":"SR Stowell","year":"2014","unstructured":"Stowell SR, Girard-Pierce KR, Smith NH, Henry KL, Arthur CM, Zimring JC, Hendrickson JE (2014) Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies. Transfusion 54:179\u2013189","journal-title":"Transfusion"},{"key":"1_CR249","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629608","volume":"12","author":"A Jash","year":"2021","unstructured":"Jash A, Usaneerungrueng C, Howie HL, Qiu A, Luckey CJ, Zimring JC, Hudson KE (2021) Antibodies to low-copy number RBC alloantigen convert a Tolerogenic stimulus to an immunogenic stimulus in mice. Front Immunol 12:629608","journal-title":"Front Immunol"},{"key":"1_CR250","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1182\/bloodadvances.2020002695","volume":"5","author":"CM Arthur","year":"2021","unstructured":"Arthur CM, Allen JWL, Verkerke H, Yoo J, Jajosky RP, Girard-Pierce K, Chonat S, Zerra P, Maier C, Rha J, Fasano R, Josephson CD, Roback JD, Stowell SR (2021) Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice. Blood Adv 5:527\u2013538","journal-title":"Blood Adv"},{"key":"1_CR251","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.4049\/jimmunol.1700401","volume":"199","author":"DR Gibb","year":"2017","unstructured":"Gibb DR, Liu J, Natarajan P, Santhanakrishnan M, Madrid DJ, Eisenbarth SC, Zimring JC, Iwasaki A, Hendrickson JE (2017) Type I IFN is necessary and sufficient for inflammation-induced red blood cell Alloimmunization in mice. J Immunol 199:1041\u20131050","journal-title":"J Immunol"},{"key":"1_CR252","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1111\/j.1537-2995.2006.00966.x","volume":"46","author":"SA Campbell-Lee","year":"2006","unstructured":"Campbell-Lee SA, Liu J, Velliquette RW, Halverson GR, Shirey RS, Chaudhuri A, Reid ME, Ness PM, Baldwin WM (2006) The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice. Transfusion 46:1682\u20131688","journal-title":"Transfusion"},{"key":"1_CR253","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080460","volume":"8","author":"D Goossens","year":"2013","unstructured":"Goossens D, da Silva N, Metral S, Cortes U, Callebaut I, Picot J, Mouro-Chanteloup I, Cartron JP (2013) Mice expressing RHAG and RHD human blood group genes. PLoS One 8:e80460","journal-title":"PLoS One"},{"key":"1_CR254","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1084\/jem.20151720","volume":"213","author":"S Calabro","year":"2016","unstructured":"Calabro S, Gallman A, Gowthaman U, Liu D, Chen P, Liu J, Krishnaswamy JK, Nascimento MS, Xu L, Patel SR, Williams A, Tormey CA, Hod EA, Spitalnik SL, Zimring JC, Hendrickson JE, Stowell SR, Eisenbarth SC (2016) Bridging channel dendritic cells induce immunity to transfused red blood cells. J Exp Med 213:887\u2013896","journal-title":"J Exp Med"},{"key":"1_CR255","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.3324\/haematol.2016.149278","volume":"101","author":"A Arneja","year":"2016","unstructured":"Arneja A, Salazar JE, Jiang W, Hendrickson JE, Zimring JC, Luckey CJ (2016) Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization. Haematologica 101:e440\u2013e444","journal-title":"Haematologica"},{"key":"1_CR256","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1111\/trf.15482","volume":"59","author":"D Liu","year":"2019","unstructured":"Liu D, Gibb DR, Escamilla-Rivera V, Liu J, Santhanakrishnan M, Shi Z, Xu L, Eisenbarth SC, Hendrickson JE (2019) Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model. Transfusion 59:3243\u20133252","journal-title":"Transfusion"},{"key":"1_CR257","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/trf.16872","volume":"62","author":"CM Arthur","year":"2022","unstructured":"Arthur CM, Patel SR, Sharma A, Zerra PE, Chonat S, Jajosky RP, Fasano RM, Patel R, Bennett A, Zhou X, Luckey CJ, Hudson KE, Eisenbarth SC, Josephson CD, Roback JD, Hendrickson JE, Stowell SR (2022) Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice. Transfusion 62:948\u2013953","journal-title":"Transfusion"},{"key":"1_CR258","doi-asserted-by":"crossref","unstructured":"Mener A, Patel SR, Arthur CM, Chonat S, Wieland A, Santhanakrishnan M, Liu J, Maier CL, Jajosky RP, Girard-Pierce K, Bennett A, Zerra PE, Smith NH, Hendrickson JE, Stowell SR (2018) Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses. JCI Insight Nov 15;3(22):e121631","DOI":"10.1172\/jci.insight.121631"},{"key":"1_CR259","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3389\/fimmu.2018.00676","volume":"9","author":"A Mener","year":"2018","unstructured":"Mener A, Arthur CM, Patel SR, Liu J, Hendrickson JE, Stowell SR (2018) Complement component 3 negatively regulates antibody response by modulation of red blood cell antigen. Front Immunol 9:676","journal-title":"Front Immunol"},{"key":"1_CR260","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.4049\/jimmunol.159.7.3278","volume":"159","author":"S Sato","year":"1997","unstructured":"Sato S, Miller AS, Howard MC, Tedder TF (1997) Regulation of B lymphocyte development and activation by the CD19\/CD21\/CD81\/Leu 13 complex requires the cytoplasmic domain of CD19. J Immunol 159:3278\u20133287","journal-title":"J Immunol"},{"key":"1_CR261","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.iy.13.040195.001015","volume":"13","author":"DT Fearon","year":"1995","unstructured":"Fearon DT, Carter RH (1995) The CD19\/CR2\/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 13:127\u2013149","journal-title":"Annu Rev Immunol"},{"key":"1_CR262","first-page":"2642","volume":"141","author":"R Jajosky","year":"2023","unstructured":"Jajosky R, Patel SR, Wu SC, Patel K, Covington M, Vallecillo-Zuniga M, Ayona D, Bennett A, Luckey CJ, Hudson KE, Hendrickson JE, Eisenbarth SC, Josephson CD, Zerra PE, Stowell SR, Arthur CM (2023) Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice. Blood 141:2642\u20132653","journal-title":"Blood"},{"key":"1_CR263","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1182\/blood-2009-08-238568","volume":"115","author":"KE Hudson","year":"2010","unstructured":"Hudson KE, Lin E, Hendrickson JE, Lukacher AE, Zimring JC (2010) Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood 115:3989\u20133996","journal-title":"Blood"},{"key":"1_CR264","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1111\/j.1537-2995.2011.03162.x","volume":"51","author":"JE Hendrickson","year":"2011","unstructured":"Hendrickson JE, Hod EA, Cadwell CM, Eisenbarth SC, Spiegel DA, Tormey CA, Spitalnik SL, Zimring JC (2011) Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity. Transfusion 51:2445\u20132454","journal-title":"Transfusion"},{"key":"1_CR265","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/trf.17251","volume":"63","author":"CL Maier","year":"2023","unstructured":"Maier CL, Jajosky RP, Patel SR, Verkerke HP, Fuller MD, Allen JW, Zerra PE, Fasano RM, Chonat S, Josephson CD, Gibb DR, Eisenbarth SC, Luckey CJ, Hudson KE, Hendrickson JE, Arthur CM, Stowell SR (2023) Storage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice. Transfusion 63:457\u2013462","journal-title":"Transfusion"},{"key":"1_CR266","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/j.1537-2995.2006.00946.x","volume":"46","author":"JE Hendrickson","year":"2006","unstructured":"Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, Zimring JC (2006) Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 46:1526\u20131536","journal-title":"Transfusion"},{"key":"1_CR267","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood-2007-03-083105","volume":"110","author":"JE Hendrickson","year":"2007","unstructured":"Hendrickson JE, Chadwick TE, Roback JD, Hillyer CD, Zimring JC (2007) Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 110:2736\u20132743","journal-title":"Blood"},{"key":"1_CR268","doi-asserted-by":"publisher","first-page":"1304086","DOI":"10.3389\/fimmu.2023.1304086","volume":"14","author":"K Paul","year":"2023","unstructured":"Paul K, Hernandez-Armengol R, Lee JY, Chang CY, Shibata T, Yamashita M, Jefferies C, Gibb DR (2023) Distinct RBC alloantibody responses in type 1 interferon-dependent and -independent lupus mouse models. Front Immunol 14:1304086","journal-title":"Front Immunol"},{"key":"1_CR269","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tmrv.2022.12.009","volume":"37","author":"SR Patel","year":"2023","unstructured":"Patel SR, Maier CL, Zimring JC (2023) Alloantigen copy number as a critical factor in RBC Alloimmunization. Transfus Med Rev 37:21\u201326","journal-title":"Transfus Med Rev"},{"key":"1_CR270","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.4049\/jimmunol.1601736","volume":"198","author":"CM Arthur","year":"2017","unstructured":"Arthur CM, Patel SR, Smith NH, Bennett A, Kamili NA, Mener A, Gerner-Smidt C, Sullivan HC, Hale JS, Wieland A, Youngblood B, Zimring JC, Hendrickson JE, Stowell SR (2017) Antigen density dictates immune responsiveness following red blood cell transfusion. J Immunol 198:2671\u20132680","journal-title":"J Immunol"},{"key":"1_CR271","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3324\/haematol.2022.281767","volume":"108","author":"A Jash","year":"2023","unstructured":"Jash A, Howie HL, Hay AM, Luckey CJ, Hudson KE, Thomson PC, Ratcliffe SJ, Smolkin M, Zimring JC (2023) Identification of multiple genetic loci associated with red blood cell alloimmunization in mice. Haematologica 108:905\u2013908","journal-title":"Haematologica"},{"key":"1_CR272","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3389\/fimmu.2018.02516","volume":"9","author":"SR Patel","year":"2018","unstructured":"Patel SR, Gibb DR, Girard-Pierce K, Zhou X, Rodrigues LC, Arthur CM, Bennett AL, Jajosky RP, Fuller M, Maier CL, Zerra PE, Chonat S, Smith NH, Tormey CA, Hendrickson JE, Stowell SR (2018) Marginal zone B cells induce alloantibody formation following RBC transfusion. Front Immunol 9:2516","journal-title":"Front Immunol"},{"key":"1_CR273","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood.2020009376","volume":"138","author":"PE Zerra","year":"2021","unstructured":"Zerra PE, Patel SR, Jajosky RP, Arthur CM, McCoy JW, Allen JWL, Chonat S, Fasano RM, Roback JD, Josephson CD, Hendrickson JE, Stowell SR (2021) Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice. Blood 138:706\u2013721","journal-title":"Blood"},{"key":"1_CR274","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","volume":"130","author":"PE Zerra","year":"2017","unstructured":"Zerra PE, Cox C, Baldwin WH, Patel SR, Arthur CM, Lollar P, Meeks SL, Stowell SR (2017) Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia a. Blood 130:2559\u20132568","journal-title":"Blood"},{"key":"1_CR275","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1182\/bloodadvances.2022008411","volume":"7","author":"A Couvidou","year":"2023","unstructured":"Couvidou A, Angenieux C, Ruch L, Mangin PH, Gachet C, Maitre B (2023) Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice. Blood Adv 7:1356\u20131365","journal-title":"Blood Adv"},{"key":"1_CR276","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/TP.0000000000004931","volume":"108","author":"MA Kallarakal","year":"2024","unstructured":"Kallarakal MA, Cohen GS, Ibukun FI, Krummey SM (2024) Marginal zone B cells are necessary for the formation of anti-donor IgG after allogeneic sensitization. Transplantation 108:1357\u20131367","journal-title":"Transplantation"},{"key":"1_CR277","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.immunol.021908.132607","volume":"27","author":"JC Weill","year":"2009","unstructured":"Weill JC, Weller S, Reynaud CA (2009) Human marginal zone B cells. Annu Rev Immunol 27:267\u2013285","journal-title":"Annu Rev Immunol"},{"key":"1_CR278","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ni1542","volume":"9","author":"G Cinamon","year":"2008","unstructured":"Cinamon G, Zachariah MA, Lam OM, Foss FW Jr, Cyster JG (2008) Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 9:54\u201362","journal-title":"Nat Immunol"},{"key":"1_CR279","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nri799","volume":"2","author":"F Martin","year":"2002","unstructured":"Martin F, Kearney JF (2002) Marginal-zone B cells. Nat Rev Immunol 2:323\u2013335","journal-title":"Nat Rev Immunol"},{"key":"1_CR280","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1146\/annurev.immunol.23.021704.115728","volume":"23","author":"S Pillai","year":"2005","unstructured":"Pillai S, Cariappa A, Moran ST (2005) Marginal zone B cells. Annu Rev Immunol 23:161\u2013196","journal-title":"Annu Rev Immunol"},{"key":"1_CR281","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1182\/blood-2013-06-508952","volume":"122","author":"KR Girard-Pierce","year":"2013","unstructured":"Girard-Pierce KR, Stowell SR, Smith NH, Arthur CM, Sullivan HC, Hendrickson JE, Zimring JC (2013) A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation. Blood 122:1793\u20131801","journal-title":"Blood"},{"key":"1_CR282","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/blood-2006-08-040139","volume":"109","author":"DA Schirmer","year":"2007","unstructured":"Schirmer DA, Song SC, Baliff JP, Harbers SO, Clynes RA, Krop-Watorek A, Halverson GR, Czerwinski M, Spitalnik SL (2007) Mouse models of IgG- and IgM-mediated hemolysis. Blood 109:3099\u20133107","journal-title":"Blood"},{"key":"1_CR283","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1537-2995.1993.33193142304.x","volume":"33","author":"RD Davenport","year":"1993","unstructured":"Davenport RD, Burdick M, Moore SA, Kunkel SL (1993) Cytokine production in IgG-mediated red cell incompatibility. Transfusion 33:19\u201324","journal-title":"Transfusion"},{"key":"1_CR284","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.3324\/haematol.2021.280493","volume":"107","author":"TLJ Van Osch","year":"2022","unstructured":"Van Osch TLJ, Oosterhoff JJ, Bentlage AEH, Nouta J, Koeleman CAM, Geerdes DM, Mok JY, Heidt S, Mulder A, Van Esch WJE, Kapur R, Porcelijn L, Van der Schoot CE, De Haas M, Wuhrer M, Voorberg J, Vidarsson G (2022) Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets. Haematologica 107:2432\u20132444","journal-title":"Haematologica"},{"key":"1_CR285","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/bjh.14053","volume":"174","author":"ME Sonneveld","year":"2016","unstructured":"Sonneveld ME, Natunen S, Sainio S, Koeleman CA, Holst S, Dekkers G, Koelewijn J, Partanen J, van der Schoot CE, Wuhrer M, Vidarsson G (2016) Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia. Br J Haematol 174:310\u2013320","journal-title":"Br J Haematol"},{"key":"1_CR286","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/bjh.12965","volume":"166","author":"R Kapur","year":"2014","unstructured":"Kapur R, Della Valle L, Sonneveld M, Hipgrave Ederveen A, Visser R, Ligthart P, de Haas M, Wuhrer M, van der Schoot CE, Vidarsson G (2014) Low anti-RhD IgG-fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. Br J Haematol 166:936\u2013945","journal-title":"Br J Haematol"},{"key":"1_CR287","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3389\/fimmu.2020.01516","volume":"11","author":"P Shinde","year":"2020","unstructured":"Shinde P, Howie HL, Stegmann TC, Hay AM, Waterman HR, Szittner Z, Bentlage AEH, Kapp L, Lissenberg-Thunnissen SN, Dekkers G, Schasfoort RBM, Ratcliffe SJ, Smolkin ME, Vidarsson G, van der Schoot CE, Hudson KE, Zimring JC (2020) IgG subclass determines suppression versus enhancement of humoral Alloimmunity to Kell RBC antigens in mice. Front Immunol 11:1516","journal-title":"Front Immunol"},{"key":"1_CR288","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s41598-019-57393-9","volume":"10","author":"BM Kumpel","year":"2020","unstructured":"Kumpel BM, Saldova R, Koeleman CAM, Abrahams JL, Ederveen AH, Armour KL, Olovnikova NI, Vidarsson G, Kapur R, Rudd PM, Wuhrer M (2020) Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG fc-glycosylation profiles that determine their clinical efficacy. Sci Rep 10:1464","journal-title":"Sci Rep"},{"key":"1_CR289","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/trf.14939","volume":"59","author":"A Mener","year":"2019","unstructured":"Mener A, Patel SR, Arthur CM, Stowell SR (2019) Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcgamma receptors in mice. Transfusion 59:371\u2013384","journal-title":"Transfusion"},{"key":"1_CR290","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/j.1537-2995.2012.03647.x","volume":"52","author":"JS Liepkalns","year":"2012","unstructured":"Liepkalns JS, Hod EA, Stowell SR, Cadwell CM, Spitalnik SL, Zimring JC (2012) Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcgamma receptors in a murine model. Transfusion 52:2631\u20132645","journal-title":"Transfusion"},{"key":"1_CR291","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1537-2995.2012.03910.x","volume":"53","author":"JS Liepkalns","year":"2013","unstructured":"Liepkalns JS, Cadwell CM, Stowell SR, Hod EA, Spitalnik SL, Zimring JC (2013) Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion. Transfusion 53:1319\u20131327","journal-title":"Transfusion"},{"key":"1_CR292","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1182\/blood-2007-04-083097","volume":"110","author":"JC Zimring","year":"2007","unstructured":"Zimring JC, Cadwell CM, Chadwick TE, Spitalnik SL, Schirmer DA, Wu T, Parkos CA, Hillyer CD (2007) Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood 110:2201\u20132208","journal-title":"Blood"},{"key":"1_CR293","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.4049\/jimmunol.1300885","volume":"191","author":"SR Stowell","year":"2013","unstructured":"Stowell SR, Liepkalns JS, Hendrickson JE, Girard-Pierce KR, Smith NH, Arthur CM, Zimring JC (2013) Antigen modulation confers protection to red blood cells from antibody through Fcgamma receptor ligation. J Immunol 191:5013\u20135025","journal-title":"J Immunol"},{"key":"1_CR294","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.3324\/haematol.2015.128603","volume":"100","author":"SR Stowell","year":"2015","unstructured":"Stowell SR, Arthur CM, Girard-Pierce KR, Sullivan HC, Santhanakrishnan M, Natarajan P, Patel SR, Tormey CA, Zimring JC, Hendrickson JE (2015) Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model. Haematologica 100:e394\u2013e397","journal-title":"Haematologica"},{"key":"1_CR295","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1182\/blood-2016-11-749432","volume":"129","author":"HC Sullivan","year":"2017","unstructured":"Sullivan HC, Gerner-Smidt C, Nooka AK, Arthur CM, Thompson L, Mener A, Patel SR, Yee M, Fasano RM, Josephson CD, Kaufman RM, Roback JD, Lonial S, Stowell SR (2017) Daratumumab (anti-CD38) induces loss of CD38 on red blood cells. Blood 129:3033\u20133037","journal-title":"Blood"},{"key":"1_CR296","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/trf.14452","volume":"58","author":"HC Sullivan","year":"2018","unstructured":"Sullivan HC, Arthur CM, Thompson L, Patel SR, Stowell SR, Hendrickson JE, Lazarus AH (2018) Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion. Transfusion 58:542\u2013544","journal-title":"Transfusion"},{"key":"1_CR297","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1182\/blood.2023020860","volume":"143","author":"Y Cruz-Leal","year":"2024","unstructured":"Cruz-Leal Y, Norris PAA, Gil Gonzalez L, Marjoram D, Wabnitz H, Shan Y, Lazarus AH (2024) Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression. Blood 143:807\u2013821","journal-title":"Blood"},{"key":"1_CR298","doi-asserted-by":"crossref","unstructured":"C. M. Jajosky RP, Liu J, Chai L, Zerra PE, Chonat S, Stowell SR, Arthur CM, CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion Front Immunol. in press, (2025)","DOI":"10.3389\/fimmu.2025.1548548"},{"key":"1_CR299","doi-asserted-by":"crossref","unstructured":"Jash A, Pridmore T, Collins JB, Hay AM, Hudson KE, Luckey CJ, Zimring JC (2024) Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. J Clin Invest 134","DOI":"10.1172\/JCI167665"},{"key":"1_CR300","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s13224-019-01234-2","volume":"69","author":"AR Chauhan","year":"2019","unstructured":"Chauhan AR, Nandanwar YS, Ramaiah A, Yelikar KA, Rashmi MD, Sachan R, Mayekar RV, Trivedi YN, Paradkar GV, Patole KP (2019) A Multicenter, Randomized, open-label trial comparing the efficacy and safety of monoclonal anti-Rh (D) immunoglobulin with polyclonal anti-Rh (D) immunoglobulin for the prevention of maternal Rh-Isoimmunization. J Obstet Gynaecol India 69:420\u2013425","journal-title":"J Obstet Gynaecol India"},{"key":"1_CR301","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1182\/bloodadvances.2019001299","volume":"4","author":"DR Gruber","year":"2020","unstructured":"Gruber DR, Richards AL, Howie HL, Hay AM, Lebedev JN, Wang X, Zimring JC, Hudson KE (2020) Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice. Blood Adv 4:1526\u20131537","journal-title":"Blood Adv"},{"key":"1_CR302","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood.2022018591","volume":"142","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP, Patel KR, Allen JWL, Zerra PE, Chonat S, Ayona D, Maier CL, Morais D, Wu SC, Luckey CJ, Eisenbarth SC, Roback JD, Fasano RM, Josephson CD, Manis JP, Chai L, Hendrickson JE, Hudson KE, Arthur CM, Stowell SR (2023) Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood 142:1082\u20131098","journal-title":"Blood"},{"key":"1_CR303","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1182\/blood-2016-01-692178","volume":"128","author":"L Bernardo","year":"2016","unstructured":"Bernardo L, Amash A, Marjoram D, Lazarus AH (2016) Antibody-mediated immune suppression is improved when blends of anti-RBC monoclonal antibodies are used in mice. Blood 128:1076\u20131080","journal-title":"Blood"},{"key":"1_CR304","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1182\/blood-2016-06-724732","volume":"128","author":"J Liu","year":"2016","unstructured":"Liu J, Santhanakrishnan M, Natarajan P, Gibb DR, Eisenbarth SC, Tormey CA, Siddon AJ, Stowell SR, Branch DR, Hendrickson JE (2016) Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice. Blood 128:3159\u20133168","journal-title":"Blood"},{"key":"1_CR305","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.4049\/jimmunol.1302287","volume":"193","author":"H Yu","year":"2014","unstructured":"Yu H, Stowell SR, Bernardo L, Hendrickson JE, Zimring JC, Amash A, Uchikawa M, Lazarus AH (2014) Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model. J Immunol 193:2902\u20132910","journal-title":"J Immunol"},{"key":"1_CR306","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.4049\/jimmunol.1500790","volume":"195","author":"L Bernardo","year":"2015","unstructured":"Bernardo L, Yu H, Amash A, Zimring JC, Lazarus AH (2015) IgG-mediated immune suppression to erythrocytes by polyclonal antibodies can occur in the absence of activating or inhibitory Fcgamma receptors in a full mouse model. J Immunol 195:2224\u20132230","journal-title":"J Immunol"},{"key":"1_CR307","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/trf.16309","volume":"61","author":"Y Cruz-Leal","year":"2021","unstructured":"Cruz-Leal Y, Lazarus AH (2021) Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression? Transfusion 61:1004\u20131006","journal-title":"Transfusion"},{"key":"1_CR308","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.704072","volume":"12","author":"V Escamilla-Rivera","year":"2021","unstructured":"Escamilla-Rivera V, Santhanakrishnan M, Liu J, Gibb DR, Forsmo JE, Foxman EF, Eisenbarth SC, Luckey CJ, Zimring JC, Hudson KE, Stowell SR, Hendrickson JE (2021) Complement plays a critical role in inflammation-induced Immunoprophylaxis failure in mice. Front Immunol 12:704072","journal-title":"Front Immunol"},{"key":"1_CR309","doi-asserted-by":"publisher","first-page":"1475470","DOI":"10.3389\/fimmu.2024.1475470","volume":"15","author":"RP Jajosky","year":"2024","unstructured":"Jajosky RP, Ayona D, Mener A, Stowell SR, Arthur CM (2024) Dynamics of antibody engagement of red blood cells in vivo and in vitro. Front Immunol 15:1475470","journal-title":"Front Immunol"},{"key":"1_CR310","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1182\/bloodadvances.2018018408","volume":"2","author":"CL Maier","year":"2018","unstructured":"Maier CL, Mener A, Patel SR, Jajosky RP, Bennett AL, Arthur CM, Hendrickson JE, Stowell SR (2018) Antibody-mediated immune suppression by antigen modulation is antigen-specific. Blood Adv 2:2986\u20133000","journal-title":"Blood Adv"},{"key":"1_CR311","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/trf.17284","volume":"63","author":"H Wabnitz","year":"2023","unstructured":"Wabnitz H, Cruz-Leal Y, Lazarus AH (2023) Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine model. Transfusion 63:696\u2013702","journal-title":"Transfusion"},{"key":"1_CR312","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.4049\/jimmunol.1700874","volume":"200","author":"Y Cruz-Leal","year":"2018","unstructured":"Cruz-Leal Y, Marjoram D, Lazarus AH (2018) Erythrocyte saturation with IgG is required for inducing antibody-mediated immune suppression and impacts both erythrocyte clearance and antigen-modulation mechanisms. J Immunol 200:1295\u20131305","journal-title":"J Immunol"},{"key":"1_CR313","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1537-2995.2004.03393.x","volume":"44","author":"RG Strauss","year":"2004","unstructured":"Strauss RG, Mock DM, Widness JA, Johnson K, Cress G, Schmidt RL (2004) Posttransfusion 24-hour recovery and subsequent survival of allogeneic red blood cells in the bloodstream of newborn infants. Transfusion 44:871\u2013876","journal-title":"Transfusion"},{"key":"1_CR314","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/trf.16849","volume":"62","author":"DM Mock","year":"2022","unstructured":"Mock DM, Stowell SR, Franco RS, Kyosseva SV, Nalbant D, Schmidt RL, Cress GA, Strauss RG, Cancelas JA, von Goetz M, North AK, Widness JA (2022) Antibodies against biotin-labeled red blood cells can shorten posttransfusion survival. Transfusion 62:770\u2013782","journal-title":"Transfusion"},{"key":"1_CR315","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/trf.17857","volume":"64","author":"MEM Yee","year":"2024","unstructured":"Yee MEM, Covington ML, Zerra PE, McCoy JW, Easley KA, Joiner CH, Bryksin J, Francis RO, Lough CM, Patel N, Kutlar A, Josephson CD, Roback JD, Stowell SR, Fasano RM (2024) Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease. Transfusion 64:1109\u20131115","journal-title":"Transfusion"},{"key":"1_CR316","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/trf.17800","volume":"64","author":"MEM Yee","year":"2024","unstructured":"Yee MEM, Zerra PE, McCoy JW, Covington ML, Stowell SR, Joiner CH, Lough CM, Delvadia BB, Josephson CD, Roback JD, Fasano RM (2024) Post-transfusion biotin-labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance. Transfusion 64:800\u2013807","journal-title":"Transfusion"},{"key":"1_CR317","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tmrv.2018.07.004","volume":"33","author":"TN Tong","year":"2019","unstructured":"Tong TN, Cen S, Branch DR (2019) The monocyte monolayer assay: past, present and future. Transfus Med Rev 33:24\u201328","journal-title":"Transfus Med Rev"},{"key":"1_CR318","first-page":"61","volume":"39","author":"SJT Nance","year":"2023","unstructured":"Nance SJT (2023) The monocyte monolayer assay, an in vitro method for prediction of in vivo survival of transfused incompatible red blood cells: a review. Immunohematology 39:61\u201369","journal-title":"Immunohematology"},{"key":"1_CR319","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/j.1537-2995.2004.03427.x","volume":"44","author":"PA Arndt","year":"2004","unstructured":"Arndt PA, Garratty G (2004) A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 44:1273\u20131281","journal-title":"Transfusion"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:49:51Z","timestamp":1788302991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":319,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}